<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">105989</article-id>
<article-id pub-id-type="doi">10.7554/eLife.105989</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.105989.2</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.2</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Cell Biology</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
</subj-group>
</article-categories><title-group>
<article-title>CO<sub>2</sub>-dependent opening of Connexin 43 hemichannels</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Dospinescu</surname>
<given-names>Valentin-Mihai</given-names>
</name>
<xref ref-type="author-notes" rid="n1">*</xref>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Mascarenhas</surname>
<given-names>Alexander</given-names>
</name>
<xref ref-type="author-notes" rid="n1">*</xref>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Butler</surname>
<given-names>Jack</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nijjar</surname>
<given-names>Sarbjit</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Oliveira Taborda</surname>
<given-names>Kyara</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Connors</surname>
<given-names>Sean</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Lumei</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2196-2949</contrib-id>
<name>
<surname>Dale</surname>
<given-names>Nicholas</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<email>N.E.Dale@warwick.ac.uk</email>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01a77tt86</institution-id><institution>School of Life Sciences, University of Warwick</institution></institution-wrap>, <city>Coventry</city>, <country country="GB">United Kingdom</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Jiang</surname>
<given-names>Jean X</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/02f6dcw23</institution-id><institution>The University of Texas Health Science Center at San Antonio</institution>
</institution-wrap>
<city>San Antonio</city>
<country country="US">United States</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Swartz</surname>
<given-names>Kenton J</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/01s5ya894</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution>
</institution-wrap>
<city>Bethesda</city>
<country country="US">United States</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn id="n1" fn-type="equal"><label>*</label><p>Co-first authors</p></fn>
<fn fn-type="coi-statement"><p>Competing interests: No competing interests declared</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2025-04-23">
<day>23</day>
<month>04</month>
<year>2025</year>
</pub-date>
<pub-date date-type="update" iso-8601-date="2025-11-14">
<day>14</day>
<month>11</month>
<year>2025</year>
</pub-date>
<volume>14</volume>
<elocation-id>RP105989</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2025-01-17">
<day>17</day>
<month>01</month>
<year>2025</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2025-01-13">
<day>13</day>
<month>01</month>
<year>2025</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2025.01.13.632711"/>
</event>
<event>
<event-desc>Reviewed preprint v1</event-desc>
<date date-type="reviewed-preprint" iso-8601-date="2025-04-23">
<day>23</day>
<month>04</month>
<year>2025</year>
</date>
<self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.105989.1"/>
<self-uri content-type="editor-report" xlink:href="https://doi.org/10.7554/eLife.105989.1.sa3">eLife Assessment</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.105989.1.sa2">Reviewer #1 (Public review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.105989.1.sa1">Reviewer #2 (Public review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.105989.1.sa0">Reviewer #3 (Public review):</self-uri>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2025, Dospinescu et al</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Dospinescu et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-105989-v2.pdf"/>
<abstract>
<p>Sequence and structure comparisons between alpha and beta connexins, Cx43 and Cx26, revealed that Cx43 has a motif, the carbamylation motif, that confers CO<sub>2</sub>-sensitivity on a subset of beta connexins. By using a fluorescent dye loading assay, whole cell patch clamp recordings and real time measurement of ATP release via GRAB<sub>ATP</sub> we have demonstrated that Cx43 hemichannels open in a highly CO<sub>2</sub> sensitive manner over the range 20 to 70 mmHg. Mutational analysis confirms that the equivalent residues to those in Cx26 that have been shown to be involved in mediating the effects of CO<sub>2</sub> on gating of hemichannels and gap junction channels, also mediate Cx43 hemichannel gating. Our data predicts that Cx43 will be partially open and able to release ATP at resting physiological levels of PCO<sub>2</sub>. We have tested this prediction in acute hippocampal slices, by showing that CO<sub>2</sub>-dependent enhancement of synaptic transmission can be blocked by the Cx43-selective mimetic peptide Gap26. Our data resolves an inconsistency in the literature between <italic>in vivo</italic> studies suggesting that Cx43 hemichannels are at least partially open at rest, and <italic>in vitro</italic> studies, performed in the absence of HCO<sub>3-</sub>/CO<sub>2</sub> buffering that show Cx43 hemichannels are shut. Our evidence suggests that the ancestral gene that duplicated to give the alpha and beta connexin clades must have possessed the carbamylation motif. CO<sub>2</sub> sensitivity is thus a fundamental ancient characteristic of several connexins that has been lost in more recently derived members of this gene family.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Key words</title>
<kwd>connexin</kwd>
<kwd>CO<sub>2</sub></kwd>
<kwd>hemichannel</kwd>
<kwd>carbamylation</kwd>
<kwd>carboxylation</kwd>
</kwd-group>
<funding-group>
<award-group id="funding-1">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/00cwqg982</institution-id>
<institution>Biotechnology and Biological Sciences Research Council</institution>
</institution-wrap>
</funding-source>
<award-id>BB/T013346/1</award-id>
</award-group>
<award-group id="funding-1a">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/00cwqg982</institution-id>
<institution>Biotechnology and Biological Sciences Research Council</institution>
</institution-wrap>
</funding-source>
<award-id>BB/T00746X/1</award-id>
</award-group>
<award-group id="funding-2">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/03x94j517</institution-id>
<institution>Medical Research Council</institution>
</institution-wrap>
</funding-source>
<award-id>MR/N014294/1</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>This revision takes into account the points raised in the public reviews.</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>There are 21 connexin genes encoded in the human genome. Connexins are transmembrane proteins that can form hemichannels and gap junction channels. The existence of 21 isoforms suggests functional specialisation across the gene family (<xref ref-type="bibr" rid="c51">Sohl &amp; Willecke, 2004</xref>). On the basis of molecular phylogeny, the connexins have been divided into 4 broad clades - the alpha, beta, and gamma and delta groupings (<xref rid="c37" ref-type="bibr">Mikalsen <italic>et al</italic>., 2021</xref>).</p>
<p>Certain members of the β-clade, Cx26, Cx30 and Cx32, are directly sensitive to CO<sub>2</sub> (<xref ref-type="bibr" rid="c24">Huckstepp <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="c14">Dospinescu <italic>et al</italic>., 2019</xref>). The mechanism of CO<sub>2</sub> sensitivity has best been studied in Cx26. While Cx26 hemichannels are opened in response to CO<sub>2</sub> (<xref ref-type="bibr" rid="c24">Huckstepp <italic>et al</italic>., 2010</xref>), CO<sub>2</sub> closes Cx26 gap junction channels (<xref ref-type="bibr" rid="c42">Nijjar <italic>et al</italic>., 2021</xref>). The CO<sub>2</sub>-dependent gating of Cx26 hemichannels and gap junction channels involves carbamylation of a specific lysine, K125, which is part of a critical carbamylation motif, <sub>125</sub>KVRIEGS<sub>131</sub> (<xref ref-type="bibr" rid="c35">Meigh <italic>et al</italic>., 2013</xref>). This motif is essential for the CO<sub>2</sub>-sensitivity of Cx26, as it allows the formation of a salt bridge between the carbamylated K125 and R104 of the neighbouring subunit (<xref ref-type="bibr" rid="c35">Meigh <italic>et al</italic>., 2013</xref>). The formation of this “carbamate” bridge induces conformational changes, ultimately leading to the opening of the hemichannel or closing of the gap junction channel (<xref ref-type="bibr" rid="c35">Meigh <italic>et al</italic>., 2013</xref>; <xref ref-type="bibr" rid="c42">Nijjar <italic>et al</italic>., 2021</xref>; <xref ref-type="bibr" rid="c2">Brotherton <italic>et al</italic>., 2022</xref>; <xref ref-type="bibr" rid="c1">Brotherton <italic>et al</italic>., 2024</xref>). Mutation of K125 to arginine, an amino acid that cannot be carbamylated, or R104 to alanine so that it cannot form a carbamate bridge, removes the ability of CO<sub>2</sub> to open Cx26 hemichannels (<xref ref-type="bibr" rid="c35">Meigh <italic>et al</italic>., 2013</xref>) or close Cx26 gap junction channels (<xref ref-type="bibr" rid="c42">Nijjar <italic>et al</italic>., 2021</xref>; <xref ref-type="bibr" rid="c41">Nijjar <italic>et al</italic>., 2025</xref>). Furthermore, the introduction of the carbamylation motif into a CO<sub>2</sub>-insensitive connexin, Cx31, results in CO<sub>2</sub>-dependent hemichannel opening of Cx31 (<xref ref-type="bibr" rid="c35">Meigh <italic>et al</italic>., 2013</xref>). Other members of the β-clade, Cx30 and Cx32, are also CO<sub>2</sub>-sensitive, but have different sensitivity profiles (<xref ref-type="bibr" rid="c24">Huckstepp <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="c14">Dospinescu <italic>et al</italic>., 2019</xref>). Evolutionary comparisons show that the carbamylation motif has been conserved over 400 million years (<xref ref-type="bibr" rid="c14">Dospinescu <italic>et al</italic>., 2019</xref>) and appears to be a necessary and sufficient feature for the CO<sub>2</sub>-sensitivity of connexins.</p>
<p>Sequence comparisons of the β-connexins and α-connexins, revealed the presence of a potential carbamylation motif within the α-connexin, Cx43. Cx43 has a motif (<sub>144</sub>KVKMRGG<sub>150</sub>) homologous to the motif in Cx26 (<sub>125</sub>KVRIEGS<sub>131</sub>) suggesting that it might also be sensitive to CO<sub>2</sub>. In this study we show that Cx43 hemichannels are indeed directly sensitive to changes in the partial pressure of CO<sub>2</sub> (PCO<sub>2</sub>) over the physiological concentration range. Unlike Cx26, the CO<sub>2</sub>-dependent opening mechanism of Cx43 is more complex, involving additional residues beyond the homologs of K125 and R104 in Cx26. Our discovery that Cx43 hemichannels are directly CO<sub>2</sub> sensitive has major physiological implications and may explain why Cx43 hemichannels appear to be open under physiological conditions but closed <italic>in vitro</italic> where they are usually studied in the absence of CO<sub>2</sub>/HCO<sub>3-</sub>buffers.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Identification of a potential carbamylation motif in Cx43</title>
<p>Cx43, an alpha-connexin, possesses a carbamylation motif homologous to that of the beta-connexins (<xref rid="fig1" ref-type="fig">Fig 1A</xref>). AlphaFold3 (AF3) predicts a structure very close to the experimentally determined structures for Cx43 (<xref ref-type="bibr" rid="c31">Lee <italic>et al</italic>., 2023a</xref>; <xref ref-type="bibr" rid="c44">Qi <italic>et al</italic>., 2023</xref>) but has the advantage of including portions of the structure that have not been experimentally resolved. This is a valid approach, as the <italic>de novo</italic> predictions by AF3 for the cytoplasmic loop of Cx26 have been supported by a recent experimentally-derived structure (<xref ref-type="bibr" rid="c1">Brotherton <italic>et al</italic>., 2024</xref>). By performing alignments of the Cx43 and Cx26 AF3 structures (<xref rid="fig1" ref-type="fig">Fig 1B</xref>), we found that two residues in Cx43, K144 and K105, aligned with the residues in Cx26 that are essential for hemichannel opening to CO<sub>2</sub>, K125 and R104 (<xref rid="fig1" ref-type="fig">Fig 1C</xref>). The predicted 3D orientation of the alpha-helices involved are positioned in a similar manner to allow potential interaction between K144 and K105 following carbamylation. Cx43 also presents another feature that is similar to Cx26: the high incidence of Lys residues. In Cx26, 5 lysine residues in the cytoplasmic loop can be carbamylated (<xref ref-type="bibr" rid="c41">Nijjar <italic>et al</italic>., 2025</xref>), suggesting an environment favourable for this to happen. The presence of multiple Lys residues in the cytoplasmic loop of Cx43 implies that the local environment may be conserved to facilitate the required pKa for CO<sub>2</sub> binding and carbamate bridge formation.</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1:</label>
<caption><title>Structures of Cx43 and Cx26 predicted by AF3.</title>
<p>(<bold>A</bold>) α- and β-connexin sequence alignment with the known CO<sub>2</sub>-sensitive connexins at the top, Cx26, Cx30 and Cx32, followed by the α-connexin Cx43. The carbamylation motif is highlighted by the green box. (<bold>B</bold>) Cx26 and Cx43 AlphaFold3 structural alignments. (<bold>C</bold>) Cx26 and Cx43 hemichannel structural prediction.</p></caption>
<graphic xlink:href="632711v2_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2b">
<title>Cx43 hemichannels are opened by CO<sub>2</sub></title>
<p>We used an established dye-loading protocol, previously used for CO<sub>2</sub> connexin studies (<xref ref-type="bibr" rid="c24">Huckstepp <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="c35">Meigh <italic>et al</italic>., 2013</xref>; <xref ref-type="bibr" rid="c36">Meigh <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="c13">de Wolf <italic>et al</italic>., 2016</xref>; <xref ref-type="bibr" rid="c12">de Wolf <italic>et al</italic>., 2017</xref>; <xref ref-type="bibr" rid="c7">Cook <italic>et al</italic>., 2019</xref>; <xref ref-type="bibr" rid="c14">Dospinescu <italic>et al</italic>., 2019</xref>; <xref ref-type="bibr" rid="c56">van de Wiel <italic>et al</italic>., 2020</xref>), to test whether Cx43 hemichannels are CO<sub>2</sub> sensitive. We observed significant dye-loading in Cx43-expressing cells when exposed to a high CO<sub>2</sub> stimulus (70 mmHg) when starting from a baseline of 20 mmHg (MW test, PCO<sub>2</sub> 20 vs 70 mmHg: p = 0.008, n=5, <xref rid="fig2" ref-type="fig">Fig 2A</xref>). We used a zero Ca<sup>2+</sup> aCSF to unblock hemichannels as a positive control to demonstrate that for WT Cx43, the zero Ca<sup>2+</sup> stimulus and 70 mmHg PCO<sub>2</sub> gave a similar amount of dye loading (MW test: p-value = 0.726, n=5).</p>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2:</label>
<caption><title>Cx43 hemichannels can be opened by an increase in PCO<sub>2</sub>.</title>
<p>The CO<sub>2</sub> sensitivity of Cx43 was assayed using three different methods. <bold>(A)</bold> Dye-loading with CBF from 20 (left) to 70 mmHg PCO<sub>2</sub> (right). The inset represents the 0 Ca<sup>2+</sup> control, white scale bar is 20 μm. Cumulative probability graph represents all the data points measured with more than 200 cells per condition, box plot shows the medians from each independent transfection. <bold>(B)</bold> Whole cell patch recordings performed on untransfected parental HeLa cells and HeLa cells expressing Cx43 at a holding potential of −50 mV with steps to −40 mV to measure whole cell conductance. The baseline was set to 35 mmHg PCO<sub>2</sub> and three different concentrations were used (20, 55, 70 mmHg). The absolute conductance change evoked by a change in PCO<sub>2</sub> was measured and plotted as a dose response curve (right side, median with interquartile range) with 20 mmHg being assigned to zero and the absolute value of all conductance changes plotted relative to this (see Methods for details). The points were fitted by the Hill equation H=6, EC<sub>50</sub>=43 mmHg (blue points, orange curve). The data for untransfected parental HeLa cells was plotted the same way (grey). <bold>(C)</bold> The genetically-encoded ATP sensor GRAB<sub>ATP</sub> was co-transfected alongside Cx43 into HeLa cells (n=22). Representative images at different PCO<sub>2</sub> concentrations of the cells are shown, grey scale bar is 20 μm. Traces from the recording the images were selected from are shown; each line represent a different cell, the fluorescence was normalised by dividing all values by the baseline median pixel intensity before plotting. Box plot shows the µM ATP release as determined by normalisation to the 3 µM control solution applied. <bold>(D)</bold> Parental HeLa cells transfected only with GRAB<sub>ATP</sub> do not exhibit CO<sub>2</sub> dependent ATP release (n=14), summary box plot shows the µM ATP release as determined by normalisation to 3 µM ATP calibration.</p></caption>
<graphic xlink:href="632711v2_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig2_S1" position="float" fig-type="figure">
<label>Figure 2, figure supplement 1:</label>
<caption><title>Cx43 hemichannels with a truncated C-terminus (Cx43<sup>1-256</sup>) retain their sensitivity to CO<sub>2</sub> and depolarisation.</title>
<p><bold>(A)</bold> Changes in GRAB<sub>ATP</sub> fluorescence induced by changing PCO<sub>2</sub> from 20 to 55 mmHg or KCl from 3 to 50 mM. <bold>(B)</bold> Summary graph showing the concentration of ATP release in response to 55 mmHg PCO<sub>2</sub> and 50 mM KCl, n=41 cells from 3 independent transfections.</p></caption>
<graphic xlink:href="632711v2_fig2_S1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig2_S2" position="float" fig-type="figure">
<label>Figure 2, figure supplement 2:</label>
<caption><title>Effect of hypercapnic solutions on intracellular pH (pH<sub>i</sub>) of parental HeLa cells measured by BCECF fluorescence.</title>
<p><bold>(A)</bold> Images showing BCECF fluorescence at 35, 55 and 70 mmHg, and then calibration to pH 7.0, 7.2 and 7.4 of the same cells after treatment with nigericin. <bold>(B)</bold> Quantification of the changes in fluorescence. C) Summary plot of the change in pH<sub>i</sub> induced by 55 and 70 mmHg PCO<sub>2</sub>. 3 independent seeds of cells, n=30.</p></caption>
<graphic xlink:href="632711v2_fig2_S2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig2_S3" position="float" fig-type="figure">
<label>Figure 2, figure supplement 3:</label>
<caption><title>Cx43 gap junction channels are insensitive to changes in PCO<sub>2</sub>.</title>
<p><bold>(A)</bold> DIC image with mCherry fluorescence superimposed. Gap junctions are evident as red stripes between cells (yellow arrows). The fluorescence images show the patch pipette filled with NBDG its loading into the recorded cell and the neighbouring cells coupled via gap junctions. The numbers in each bottom left corner are the time of the recording from whole cell breakthrough in minutes. Scale bar 20 µm. <bold>(B)</bold> Summary graphs showing the time for the acceptor cell to reach 10% of the fluorescence of the donor cell at three different levels of PCO<sub>2</sub> (n=6 for each condition).</p></caption>
<graphic xlink:href="632711v2_fig2_S3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To further support these findings, we next used whole cell patch clamp recordings from HeLa cells expressing Cx43 (<xref rid="fig2" ref-type="fig">Fig 2B</xref>). We set the holding potential to −50 mV and gave regular steps to −40 mV to measure whole cell conductance. From a baseline of 35 mmHg PCO<sub>2</sub>, an increase in an outward conductance was observed when switching to 55 or 70 mmHg aCSF (<xref rid="fig2" ref-type="fig">Fig 2B</xref>). On switching to 20 mmHg aCSF, a small conductance decrease and reduction of outward current was observed (<xref rid="fig2" ref-type="fig">Fig 2B</xref>). Untransfected parental HeLa cells did not display changes in outward current to changes in PCO<sub>2</sub>. However, some parental HeLa cells exhibited a slow increase in an inward current on transfer from 35 to 70 mmHg (<xref rid="fig2" ref-type="fig">Fig 2B</xref>). This was quite distinct from the outward current observed in Cx43 expressing cells (<xref rid="fig2" ref-type="fig">Fig 2B</xref>). Overall, the patch clamp data predicted a dose response that could be fitted by the Hill equation with a Hill coefficient of 6 and an EC<sub>50</sub> of 43 mmHg. This is similar to Cx26 hemichannels which also display a steep CO<sub>2</sub> dose response curve with a Hill coefficient of &gt;4 (<xref ref-type="bibr" rid="c24">Huckstepp <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="c12">de Wolf <italic>et al</italic>., 2017</xref>; <xref ref-type="bibr" rid="c56">van de Wiel <italic>et al</italic>., 2020</xref>).</p>
<p>To assess whether the CO<sub>2</sub>-dependent opening of Cx43 resulted in ATP release, we co-transfected HeLa cells with the genetically encoded ATP sensor - GRAB<sub>ATP</sub> (<xref ref-type="bibr" rid="c60">Wu <italic>et al</italic>., 2022</xref>). CO<sub>2</sub> dependent increase in ATP release was indeed observed (n=22, <xref rid="fig2" ref-type="fig">Fig 2C</xref>). We observed an increase in GRAB<sub>ATP</sub> fluorescence on going from 20 to 35 mmHg PCO<sub>2</sub> and further to 55 mmHg PCO<sub>2</sub> (<xref rid="fig2" ref-type="fig">Fig 2C</xref>). While ATP release at 70 mmHg was slightly less than that at 55 mmHg, it remained markedly higher than at 35 mmHg PCO<sub>2</sub> (<xref rid="fig2" ref-type="fig">Fig 2C</xref>). By contrast, HeLa cells that were not transfected with Cx43 showed no responses to any applied CO<sub>2</sub> concentration as concluded from GRAB<sub>ATP</sub> experiments (n=14, <xref rid="fig2" ref-type="fig">Fig 2D</xref>). Overall, our results show through three independent assays that Cx43 hemichannels are opened by modest changes in PCO<sub>2</sub> around the physiological norm and will be partially open at a PCO<sub>2</sub> of 35 mmHg (<xref rid="fig2" ref-type="fig">Fig 2</xref>). Once opened by CO<sub>2</sub>, Cx43 hemichannels display permeability to ATP (<xref rid="fig2" ref-type="fig">Fig 2C</xref>).</p>
<p>Cx43 displays sensitivity to intracellular pH via a sensor located in the C-terminus (<xref ref-type="bibr" rid="c17">Ek-Vitorín <italic>et al</italic>., 1996</xref>). We assessed the effect of truncations of the C-terminus of Cx43 (truncated after residue 256, Cx43<sup>1-256</sup>) that remove this pH sensor. Both CO<sub>2</sub> and high K<sup>+</sup> induced ATP release from HeLa cells that expressed Cx43<sup>1-256</sup> (<xref rid="fig2_S1" ref-type="fig">Fig 2, figure supplement 1</xref>). We also measured the effect of changing PCO<sub>2</sub> on intracellular pH (pH<sub>i</sub>) of HeLa cells. We found that transferring from 35 to 55 or 70 mmHg respectively induced median changes in pH<sub>i</sub> of −0.02 (95% CI −0.02, −0.03) and −0.13 (CI −0.10, −0.15; <xref rid="fig2_S2" ref-type="fig">Fig 2, figure supplement 2</xref>). These results show that the effects of PCO<sub>2</sub> on Cx43 gating are independent of those involved in its pH sensitivity.</p>
<p>Gap Junction Channels (GJCs) of Cx26 are closed by CO<sub>2</sub> also acting via the carbamylation motif. We therefore tested whether Cx43 GJCs might also be CO<sub>2</sub> sensitive by using a dye transfer assay (<xref ref-type="bibr" rid="c42">Nijjar <italic>et al</italic>., 2021</xref>). Cx43 GJCs allowed equally fast permeation of dye at all levels of PCO<sub>2</sub> and therefore, unlike the hemichannel, were insensitive to CO<sub>2</sub> (<xref rid="fig2_S3" ref-type="fig">Fig 2, figure supplement 3</xref>).</p>
</sec>
<sec id="s2c">
<title>Identifying the residues required for CO<sub>2</sub>-sensitivity of Cx43</title>
<p>Having established the dose-response characteristics of Cx43 to CO<sub>2</sub>, we next examined the potential underlying mechanisms for CO<sub>2</sub>-dependent gating via targeted mutagenesis of possible key residues, starting with the equivalents of those known to be involved in the CO<sub>2</sub>-sensitivity of Cx26 (<xref rid="fig1" ref-type="fig">Fig 1</xref>).</p>
<p>Mutation of K144 to glutamine (K144Q), an amino acid that cannot be carbamylated, partially reduced the CO<sub>2</sub>-sensitivity of the channel: the 70 mmHg stimulus resulted in significantly less increase in dye loading than the zero Ca<sup>2+</sup> positive control (<xref rid="fig3" ref-type="fig">Fig 3A</xref>, MW test: p = 0.048, n=5). However, mutation of Lys105 to a non-charged residue (K105Q) resulted in hemichannels that gave a similar increase in dye loading to the zero Ca<sup>2+</sup> positive control (<xref rid="fig3" ref-type="fig">Fig 3B</xref>, MW test: p = 0.111, n=5). In Cx26, mutation of the residues involved in carbamylation (K125 and R104) results in complete loss of CO<sub>2</sub> sensitivity (<xref ref-type="bibr" rid="c35">Meigh <italic>et al</italic>., 2013</xref>; <xref ref-type="bibr" rid="c42">Nijjar <italic>et al</italic>., 2021</xref>). The lack of such a complete effect on the CO<sub>2</sub> sensitivity of Cx43 implies that the mechanism is more complex and may involve further residues. Interestingly, mutation of Lys144 to Arg (K144R) completely abolished the CO<sub>2</sub> sensitivity of Cx43 hemichannels as measured by dye loading (<xref rid="fig3_S1" ref-type="fig">Fig 3, figure supplement 1</xref>). The difference between the effect of mutating Lys144 to Arg and Gln on CO<sub>2</sub> sensitivity may arise because the substitution to Arg introduces a positive charge. Since K144 appears to be carbamylated, its primary amine must remain unprotonated so that the unpaired electrons of the nitrogen can mount a nucleophilic attack on the carbon of CO<sub>2</sub> to form the carbamate bond. Thus, the K144Q mutation may preserve this charge and be a better substitute that removes the capacity for carbamylation while preserving the overall charge within this region of the protein. Consequently, we have predominantly used the Lys to Gln substitution in this study.</p>
<fig id="fig3" position="float" fig-type="figure">
<label>Figure 3:</label>
<caption><title>The effect of single Lys mutations on the CO<sub>2</sub> sensitivity of Cx43.</title>
<p>HeLa cells transfected with the mutant variant of Cx43 were subjected to the dye-loading protocol. Images of dye loading in response to CO<sub>2</sub> and the 0 Ca<sup>2+</sup> positive control (insets), together with the cumulative probability plots are shown for K105Q (<bold>A</bold>), K109Q (<bold>B</bold>), K144Q (<bold>C</bold>), K234Q (<bold>D</bold>). <bold>(E)</bold> AlphaFold3 prediction of Cx43 with hypothesised carbamylation bridge residues highlighted – K234 in orange and K109 in red. <bold>(F)</bold> Summary box plots for dye-loading showing the change in median pixel intensity from 20 mmHg PCO<sub>2</sub> for each condition (70 mmHg PCO<sub>2</sub> – green and 0 Ca<sup>2+</sup> blue, n=5) for WT (recalculated data from <xref ref-type="fig" rid="fig2">Fig 2A</xref> for comparison) and each mutation. Scale bars are 20 µm.</p></caption>
<graphic xlink:href="632711v2_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig3_S1" position="float" fig-type="figure">
<label>Figure 3, figure supplement 1:</label>
<caption><title>Cx43<sup>K144R</sup> hemichannels are insensitive to changes in PCO<sub>2</sub>.</title>
<p><bold>(A)</bold> Cumulative probability plot from 5 independent transfections showing dye loading in response to 20 nd 70 mmHg and the zero Ca<sup>2+</sup> stimulus. <bold>(B)</bold> Summary graph showing the change in median fluorescence intensity caused by 70 mmHg and zero Ca<sup>2+</sup> in Cx43<sup>WT</sup> (data recalculated from <xref rid="fig2" ref-type="fig">Fig 2</xref>) and Cx43<sup>K144R</sup>.</p></caption>
<graphic xlink:href="632711v2_fig3_S1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>We further inspected the AF3 structure prediction and identified two further lysine residues of interest (<xref rid="fig3" ref-type="fig">Fig 3E</xref>). K109 in Cx43 aligns with K108 of Cx26, a residue known to be carbamylated and required for Cx26 gap junction closure (<xref ref-type="bibr" rid="c41">Nijjar <italic>et al</italic>., 2025</xref>). AF3 also suggests that K109 could potentially interact with K234 following any carbamylation (<xref rid="fig3" ref-type="fig">Fig 3E</xref>). We therefore mutated both residues to Gln to test their possible involvement in CO<sub>2</sub> sensitivity. The dye-loading assay showed that K109Q remained CO<sub>2</sub> sensitive (<xref rid="fig3" ref-type="fig">Fig 3C</xref> MW test vs zero Ca<sup>2+</sup> control, p = 0.274, n=5). However, the mutation K234Q displayed impaired CO<sub>2</sub> sensitivity (<xref rid="fig3" ref-type="fig">Fig 3D</xref>, MW test vs zero Ca<sup>2+</sup> control: p = 0.016, n=5).</p>
<p>As the dye loading assay suggested that single mutations were on the whole rather ineffective in abolishing CO<sub>2</sub> sensitivity, we assayed ATP release via GRAB<sub>ATP</sub> to gain further supporting evidence. We found that CO<sub>2</sub>-evoked ATP release remained dose dependent and very similar to the WT Cx43 in the K105Q (n=23) and K144Q (n=12) mutants (<xref rid="fig4" ref-type="fig">Fig 4A, C</xref>, <xref rid="fig4_S1" ref-type="fig">Figure 4, figure supplement 1</xref>). Cx43 hemichannels with the K109Q mutation appeared to have their sensitivity to CO<sub>2</sub> shifted to lower values of PCO<sub>2</sub> (n=20), appearing to give maximal ATP release at 35 mmHg (<xref rid="fig4" ref-type="fig">Fig 4B,E</xref>, <xref rid="fig4_S1" ref-type="fig">Fig 4 figure supplement 1</xref>). K234Q Cx43 hemichannels had greatly reduced sensitivity to CO<sub>2</sub> (n=15, <xref rid="fig4" ref-type="fig">Fig 4D, F</xref>). To check that K234Q did not have some non-specific effect on hemichannel function, we used high K<sup>+</sup> induced depolarisation as a way of opening the hemichannel independently of changes in PCO<sub>2</sub> as a positive control. This stimulus resulted in robust ATP release.</p>
<fig id="fig4" position="float" fig-type="figure">
<label>Figure 4:</label>
<caption><title>The effect of single Lys mutations on CO<sub>2</sub>-dependent ATP release from Cx43.</title>
<p>The genetically-encoded ATP sensor GRAB<sub>ATP</sub> was co-transfected alongside Cx43 mutant variations, K105Q (<bold>A</bold>) n=23, K109Q (<bold>B</bold>) n=20, K144Q (<bold>C</bold>) n=12, K234Q (<bold>D</bold>) n=15. Representative trace measurements were selected; each line represents a different cell; the fluorescence was normalised by dividing all values by the baseline median pixel intensity before plotting. Box plot on the right (<bold>E</bold>) and (<bold>F</bold>) represent the µM ATP released as determined through normalisation to the 3 µM ATP application.</p></caption>
<graphic xlink:href="632711v2_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig4_S1" position="float" fig-type="figure">
<label>Figure 4, figure supplement 1:</label>
<caption>
<title>The effect of single Lys mutations on the CO<sub>2</sub> dose-response properties of Cx43.</title>
<p>Comparison of Cx43<sup>WT</sup> (data replotted from <xref rid="fig2" ref-type="fig">Fig 2C</xref>), Cx43<sup>K105Q</sup>, Cx43<sup>K109Q</sup> (data replotted from <xref rid="fig4" ref-type="fig">Fig 4E</xref>) and Cx43<sup>K144Q</sup> (data replotted from <xref rid="fig4" ref-type="fig">Fig 4F</xref>). Data is plotted as medians with lower and upper quartiles. For the WT, K105Q and K144Q the fitted curve is drawn according to a modified Hill equation: [ATP]=Max<sub>ATP</sub>.[(PCO<sub>2</sub>/K)<sup>H</sup>/(1+(PCO<sub>2</sub>/K)<sup>H</sup>)].[1−(PCO<sub>2</sub>/K<sub>i</sub>)<sup>Hi</sup>/(1+(PCO<sub>2</sub>/K<sub>i</sub>)<sup>Hi</sup>)] Where K and H are the affinity and Hill coefficient of the channel for opening by CO<sub>2</sub>, K<sub>i</sub> and H<sub>i</sub> are the affinity and Hill coefficient for inhibition of the channel by CO<sub>2</sub>, and Max<sub>ATP</sub> is the asymptotically maximum release of ATP to CO<sub>2</sub>. For K109Q which did not exhibit CO<sub>2</sub>-dependent inhibition at high levels of PCO<sub>2</sub>, the Hill equation was used. The parameters for the curves are:</p>
</caption>
<graphic xlink:href="632711v2_fig4_S1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2d">
<title>CO<sub>2</sub> sensitivity of Cx43 involves multiple Lys residues</title>
<p>As single Lys mutations mostly had partial effects on the CO<sub>2</sub> sensitivity of Cx43 hemichannels, we next mutated pairs of Lys residues. Using the dye loading assay we found that all combinations of paired mutations abolished CO<sub>2</sub> sensitivity relative to the zero Ca<sup>2+</sup> control (<xref rid="fig5" ref-type="fig">Fig 5</xref>): K109Q, K144Q (MW test p = 0.008, n=5); K105Q, K144Q (MW test p = 0.004, n=5); K105Q, K109Q (MW test p = 0.004, n=5); K105Q, K234Q (MW test p = 0.004, n=5); and K144Q, K234Q (MW test p = 0.004, n=5). Using the GRAB<sub>ATP</sub> assay we confirmed that all of these double mutations also abolished CO<sub>2</sub>-dependent ATP release (MW test for all mutations, CO<sub>2</sub> vs high K<sup>+</sup> positive control p &lt; 10<sup>−6</sup>, <xref rid="fig6" ref-type="fig">Fig 6</xref>).</p>
<fig id="fig5" position="float" fig-type="figure">
<label>Figure 5:</label>
<caption><title>Paired Lys mutations are required to abolish the CO<sub>2</sub> sensitivity of Cx43.</title>
<p>Representative images for all combinations tried are shown – K109Q K144Q (<bold>A</bold>), K105Q K144Q (<bold>B</bold>), K105Q K109Q (<bold>C</bold>), K105Q K234Q (<bold>D</bold>), K144Q K234Q (<bold>E</bold>). Insets represent the 0 Ca<sup>2+</sup> positive control. For each construct, the pixel intensity in expressing cells was measured from 5 individual transfections, with at least 40 cells per condition. Cumulative probability plots display all measured data points. (<bold>F)</bold> The box plots shows the change in median pixel intensity from 20 mmHg PCO<sub>2</sub> for each transfection for 70 mmHg PCO<sub>2</sub> (green) and 0 Ca<sup>2+</sup> (blue).</p></caption>
<graphic xlink:href="632711v2_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="fig6" position="float" fig-type="figure">
<label>Figure 6:</label>
<caption><title>Paired Lys mutations abolish CO<sub>2</sub> dependent ATP release via Cx43.</title>
<p>HeLa cells co-expressing Cx43 and GRAB<sub>ATP</sub> were subjected to changing PCO<sub>2</sub>-levels and fluorescence was recorded. Representative traces (<bold>A-E</bold>) for each of the Cx43 mutations – K105Q K144Q (<bold>A</bold>) n=23, K109Q K144Q (<bold>B</bold>) n=19, K105Q K234Q (<bold>C</bold>) n=17, K109Q K234Q (<bold>D</bold>) n=16, K144Q K234Q (<bold>E</bold>) n=13. The traces indicate normalised fluorescence changes (ΔF/F<sub>0</sub>). 3 µM ATP was applied at the end of each experiment to confirm sensor functionality. Furthermore, as a positive control, 50 mM KCl was applied to depolarise the cells and confirm channel function. (<bold>F-G</bold>) Box plots summarising the total ATP release in µM for each double mutant in 55 mmHg PCO<sub>2</sub> and 50 mM KCl. Data points represent individual measured cells.</p></caption>
<graphic xlink:href="632711v2_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2e">
<title>The effect of introducing negatively charged residues into the carbamylation motif</title>
<p>We next sought to mimic carbamylation by mutating Lys to Glu. This introduces into the motif the negative charge that would occur upon carbamylation of Lys. In the dye loading assay the mutation K144E resulted in a complete loss of CO<sub>2</sub> sensitivity while dye loading to zero Ca<sup>2+</sup> was retained (MW test, 70 mmHg vs zero Ca<sup>2+</sup>: p = 0.008, n=5, <xref rid="fig7" ref-type="fig">Fig 7B</xref>). The mutation K105E seemed to disrupt both the CO<sub>2</sub>-dependent and the zero Ca<sup>2+</sup> evoked dye loading (<xref rid="fig7" ref-type="fig">Fig 7A</xref>). K234E displayed impaired CO<sub>2</sub>-dependent dye loading compared to that evoked by zero Ca<sup>2+</sup> (MW test, 70 mmHg vs zero Ca<sup>2+</sup>: p = 0.048, n=5, <xref rid="fig7" ref-type="fig">Fig 7C</xref>).</p>
<fig id="fig7" position="float" fig-type="figure">
<label>Figure 7:</label>
<caption><title>Introduction of negative charge into the carbamylation motif via Lys to Glu mutations has mixed effects on CO<sub>2</sub> sensitivity of Cx43 hemichannels.</title>
<p>Expressing cells pixel intensity for each construct was measured from 5 individual transfections, with at least 40 cells per condition. (<bold>A-C</bold>) Representative cell images for 20 (left), 70 (right) with insets displaying the 0 Ca<sup>2+</sup> control for each mutant K105E (<bold>A</bold>), K144E (<bold>B</bold>), K234E (<bold>C</bold>). Scale bar represents 20 µm. Cumulative probability graphs of pixel intensities are shown on the right for each mutant with three conditions 20 mmHg PCO<sub>2</sub> (blue line), 70 mmHg PCO<sub>2</sub> (orange) and 0 Ca<sup>2+</sup> (grey line). The box plot shows change in median pixel intensity from 20 mmHg PCO<sub>2</sub> for each transfection for 70 mmHg PCO<sub>2</sub> (green boxes) and 0 Ca<sup>2+</sup> (blue boxes).</p></caption>
<graphic xlink:href="632711v2_fig7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Using the GRAB<sub>ATP</sub> assay, we found that each of these single Lys to Glu mutations disrupted CO<sub>2</sub>-dependent ATP release, but did not prevent depolarisation evoked ATP release (<xref rid="fig8" ref-type="fig">Fig 8</xref>). This disruptive effect on CO<sub>2</sub> dependence might arise because introduction of the negative charge changes the local environment and makes it harder to carbamylate the other Lys residues.</p>
<fig id="fig8" position="float" fig-type="figure">
<label>Figure 8:</label>
<caption><title>Lys to Glu mutations abolish CO<sub>2</sub>-dependent ATP Release.</title>
<p>GRAB<sub>ATP</sub> fluorescence traces of ATP release from cells expressing single mutant connexins: K105E (<bold>A</bold>) n=18, K144E (<bold>B</bold>) n=17, K234E (<bold>C</bold>) n=13, in response to 55 mmHg PCO<sub>2</sub> (red bars), 50 mM KCl depolarisation control (orange bars) and a 3 µM ATP control application at the end of all experiments to confirm sensor functionality. Traces show changes in normalised fluorescence over time (ΔF/F), indicating ATP release. On the right, the box plots display the quantified ATP release in µM for each mutant under 55 mmHg PCO<sub>2</sub> and 50 mM KCl. Each data point represents a measurement from an individual cell.</p></caption>
<graphic xlink:href="632711v2_fig8.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>As a change in PCO<sub>2</sub> would likely carbamylate more than one Lys residue simultaneously, we made the double mutation K105E and K109E. With the dye loading assay we found that even at a PCO<sub>2</sub> of 20 mmHg, the cells loaded with dye suggesting that the mutated hemichannels were constitutively open (<xref rid="fig9" ref-type="fig">Fig 9A, D</xref>). Despite this cells that expressed this double mutant had normal morphology (<xref ref-type="supplementary-material" rid="supp1">Fig 9, movie supplement 1</xref>) and their cultures did not exhibit noticeably higher levels of cell death. Presumably the HeLa cells were able to adapt to the presence of these open channels.</p>
<fig id="fig9" position="float" fig-type="figure">
<label>Figure 9:</label>
<caption><title>The Cx43 double mutant, K105E K109E, is constitutively open.</title>
<p>(<bold>A</bold>) Representative fluorescence images of cells expressing the Cx43 K105E K109E mutant under low (20 mmHg PCO<sub>2</sub>, left) and high CO<sub>2</sub> (70 mmHg PCO<sub>2</sub>, right), inset shows the 0 Ca<sup>2+</sup> control. Scale bar is 20 µm. Cumulative probability plot of pixel intensity for each condition is shown on the right, overall indicating higher baseline fluorescence and perpetually open hemichannels. (<bold>B</bold>) Dye-loading with 20 mmHg PCO<sub>2</sub> (left) and 20mmHg PCO<sub>2</sub> with 100 µm LaCl<sub>3</sub>. Cumulative probability plot for pixel intensity under these conditions is shown on the right. (<bold>C</bold>) Fluorescence traces of ATP release from cells co-expressing GRAB<sub>ATP</sub> and Cx43 K105E K109E (n=16) under 20 mmHg PCO<sub>2</sub> and 20 mmHg PCO<sub>2</sub> with 100 µM LaCl<sub>3</sub> (black bar). Fluorescence is normalised to baseline. (<bold>D</bold>) Fluorescence traces of ATP release from cells co-expressing GRAB<sub>ATP</sub> and Cx43 WT under 20 mmHg PCO<sub>2</sub> and 20 mmHg PCO<sub>2</sub> with 100 µM LaCl<sub>3</sub> (black bar). (<bold>E</bold>) Box plots summarizing median pixel intensity under the different conditions, showing a significant reduction in intensity in the presence of LaCl<sub>3</sub> (p = 0.03). (<bold>F</bold>) Box plot shows normalised fluorescence changes values for the difference between – 20 mmHg PCO<sub>2</sub> (representing baseline normalisation) and the application of LaCl<sub>3</sub> for both the K105E K109E and WT Cx43 constructs.</p></caption>
<graphic xlink:href="632711v2_fig9.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Increasing PCO<sub>2</sub> to 70 mmHg gave no further dye loading. To test whether the channels were open even at a PCO<sub>2</sub> of 20 mmHg, we used the general hemichannel blocker La<sup>3+</sup> (100 µM) to show that this reduced the dye loading at 20 mmHg (<xref rid="fig9" ref-type="fig">Fig 9B, D</xref>, MW test: p = 0.016, n=5). We used the GRAB<sub>ATP</sub> assay to demonstrate that at a PCO<sub>2</sub> of 20 mmHg, the K105E, K109E mutation caused continual release of ATP that could be blocked by La<sup>3+</sup> (<xref rid="fig9" ref-type="fig">Fig 9C, D</xref>, MW test 20 mmHg vs 20 mmHg + La<sup>3+</sup>, p=7.7×10<sup>−7</sup>, n=16; <xref ref-type="supplementary-material" rid="supp1">Fig 9, movie supplement 1</xref>). This continual release of ATP at a PCO<sub>2</sub> of 20 mmHg was not evident from cells expressing WT Cx43, as application of 100 µM La<sup>3+</sup> had no effect on the GRAB<sub>ATP</sub> fluorescence (<xref rid="fig9" ref-type="fig">Fig 9C, D</xref>).</p>
</sec>
<sec id="s2f">
<title>Physiological role for CO<sub>2</sub>-dependent ATP release via Cx43 from astrocytes</title>
<p>Cx43 hemichannels are CO<sub>2</sub> sensitive and are likely to be partially open at typical levels of PCO<sub>2</sub> in mammalian tissue. They could thus be able to release ATP under physiological resting conditions (35 mmHg PCO<sub>2</sub>, <xref rid="fig2" ref-type="fig">Fig 2</xref>). Considering the ubiquitous distribution of Cx43 in astrocytes (<xref ref-type="bibr" rid="c10">de Ceglia <italic>et al</italic>., 2023</xref>) and the likely resting PCO<sub>2</sub> in the brain (<xref ref-type="bibr" rid="c23">Hogg <italic>et al</italic>., 1984</xref>), we postulated that, barring external modulatory influences, Cx43 hemichannels could continually release low levels of ATP in the hippocampus. Indeed, there exists compelling evidence for astrocytic Cx43 hemichannels being partially open under resting physiological conditions <italic>in vitro</italic> in the hippocampus (<xref ref-type="bibr" rid="c4">Chever <italic>et al</italic>., 2014</xref>). In this study when Cx43 hemichannels were blocked by the mimetic peptide, Gap26, there was a decrease synaptic strength of about 30% that was occluded by targetted knock out of astrocytic Cx43 expression (<xref ref-type="bibr" rid="c4">Chever <italic>et al</italic>., 2014</xref>).</p>
<p>As many investigators state that Cx43 hemichannels are shut under physiological conditions, we tested whether the results of <xref ref-type="bibr" rid="c4">Chever et al (2014)</xref> could be explained by the CO<sub>2</sub> sensitivity of Cx43. We predicted that if PCO<sub>2</sub> were lowered sufficiently to largely close Cx43, when PCO<sub>2</sub> was returned to the physiological norm, Cx43 should re-open and result in an increase of synaptic strength, presumably downstream of Cx43-dependent ATP release (<xref ref-type="bibr" rid="c4">Chever <italic>et al</italic>., 2014</xref>). Because ATP can be rapidly broken down to adenosine in the extracellular space (<xref ref-type="bibr" rid="c19">Frenguelli <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="c58">Wall &amp; Dale, 2013</xref>), which could then act at A1 receptors to inhibit transmission and give confounding effects, we used 8-CPT (8-cyclopentyltheophylline) to selectively block A1 receptors.</p>
<p>We preincubated hippocampal slices in 20 mmHg PCO<sub>2</sub> aCSF for 30 mins prior to recording field EPSPs (fEPSPs) in area CA1 evoked by stimulation of the Schaffer colaterals. At constant extracellular pH, in the presence of 8-CPT, elevation of PCO<sub>2</sub> from 20 to 35 mmHg resulted in a 26% increase in the magnitude of the fEPSP (n=6, <xref rid="fig10" ref-type="fig">Fig 10A</xref>). To test whether this effect was mediated via CO<sub>2</sub>-dependent opening of Cx43, we used 100 μM Gap26 to see whether this blocked the increase in fEPSP induced by 35 mmHg PCO<sub>2</sub>. Once again the fEPSP increased by about 30% on transfer to 35 mmHg aCSF (<xref rid="fig10" ref-type="fig">Fig 10B</xref>), and application of Gap26 reduced the fEPSP to below its baseline value (<xref rid="fig10" ref-type="fig">Fig 10B, D</xref>, Friedmann 2-way ANOVA: p=0.006, n=6). This was an effect specific to the Gap26 peptide as 100 μM of the scrambled peptide did not have significant effects on the amplitude of the fEPSP (<xref rid="fig10" ref-type="fig">Fig 10C, D</xref>, Friedmann 2-way ANOVA: p=0.55, n=5).</p>
<fig id="fig10" position="float" fig-type="figure">
<label>Figure 10:</label>
<caption><title>PCO<sub>2</sub>-dependent modulation of amplitude of fEPSPs in hippocampus is mediated via Cx43.</title>
<p>(<bold>A-C</bold>) Time-course plots showing the average amplitude of the normalised fEPSP (± SEM) amplitude in response to different conditions. Inserts display representative fEPSPs. (<bold>A</bold>) Control condition showing an increase in fEPSP amplitude in response to a modest change to PCO<sub>2</sub> (20 to 35 mmHg), red bar represent the application of 35 mmHg PCO<sub>2</sub>, baseline conditions – 20 mmHg PCO<sub>2</sub>. (<bold>B</bold>) EPSP responses in the presence of Gap26 (black bar) and subsequent wash. (<bold>C</bold>) EPSP responses with scrambled Gap26 peptide applied (black bar). (<bold>D</bold>) Box plots representing the normalised fEPSP size difference (baseline was subtracted) with colour coded conditions: orange – control 35 mmHg PCO<sub>2</sub>, green – Gap26 with pre (35G), after (35S Wash).</p></caption>
<graphic xlink:href="632711v2_fig10.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2g">
<title>Pathological mutations of Cx43 cause loss of CO<sub>2</sub> sensitivity</title>
<p>A prominent condition associated with mutations of Cx43 is occulodental digital dysplasia (ODDD) (<xref ref-type="bibr" rid="c29">Laird, 2014</xref>). This syndrome involves a range of conditions such as soft tissue fusion of the digits, abnormal craniofacial bone development, small eyes and loss of tooth enamel. Later in age conditions such as glaucoma, skin disease and neuropathies may become evident. As pathological mutations of other CO<sub>2</sub> sensitive connexins alter their CO<sub>2</sub> sensitivity (<xref ref-type="bibr" rid="c36">Meigh <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="c13">de Wolf <italic>et al</italic>., 2016</xref>; <xref ref-type="bibr" rid="c7">Cook <italic>et al</italic>., 2019</xref>; <xref ref-type="bibr" rid="c3">Butler &amp; Dale, 2023</xref>), we studied two pathological mutations of Cx43. The mutation L90V causes ODDD (<xref ref-type="bibr" rid="c50">Shibayama <italic>et al</italic>., 2005</xref>; <xref ref-type="bibr" rid="c28">Lai <italic>et al</italic>., 2006</xref>) and A44V causes the skin condition, erythrokeratodermia variabilis et progressiva (EKVP) (<xref ref-type="bibr" rid="c5">Cocozzelli &amp; White, 2019</xref>; <xref ref-type="bibr" rid="c53">Srinivas <italic>et al</italic>., 2019</xref>). We found that the L90V mutation removed CO<sub>2</sub> sensitivity from Cx43 by both the dye loading assay and the GRAB<sub>ATP</sub> assay (<xref rid="fig11" ref-type="fig">Fig 11</xref>). The mutation A44V blocked CO<sub>2</sub> dependent ATP release (<xref rid="fig11" ref-type="fig">Fig 11</xref>).</p>
<fig id="fig11" position="float" fig-type="figure">
<label>Figure 11:</label>
<caption><title>Pathological mutations of Cx43 remove its sensitivity to CO<sub>2</sub>.</title>
<p><bold>A</bold>,<bold>B)</bold> L90V prevents CO<sub>2</sub>-dependent dye loading. The dye loading assay shows no change in fluorescence between 20 and 70 mmHg, yet functional channels are expressed as shown by the zero Ca<sup>2+</sup> positive control (inset). Box plot shows the change in median pixel intensity from 20 mmHg PCO<sub>2</sub> to 70 mmHg PCO<sub>2</sub> (green boxes) and 0 Ca<sup>2+</sup> (blue boxes) for each transfection. <bold>C-E)</bold> GRAB<sub>ATP</sub> recordings shown that L90V and A44V also abolish CO<sub>2</sub>-dependent ATP release (baseline 20 mmHg PCO<sub>2</sub>, red bar 70 mmHg PCO<sub>2</sub>).</p></caption>
<graphic xlink:href="632711v2_fig11.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<sec id="s3a">
<title>Hemichannels of Cx43 are CO<sub>2</sub> sensitive</title>
<p>In contrast to Cx26 expression, which is restricted to specific, small regions of the brain (<xref ref-type="bibr" rid="c39">Nagy <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="c46">Rash <italic>et al</italic>., 2001</xref>; <xref ref-type="bibr" rid="c40">Nagy <italic>et al</italic>., 2011</xref>), Cx43 serves as the principal astrocytic connexin, exhibiting widespread presence throughout the brain (<xref ref-type="bibr" rid="c49">Schulz <italic>et al</italic>., 2015</xref>; <xref ref-type="bibr" rid="c61">Yin <italic>et al</italic>., 2018</xref>; <xref ref-type="bibr" rid="c10">de Ceglia <italic>et al</italic>., 2023</xref>). This widespread distribution, combined with our results, suggests that Cx43 gives the capacity for CO<sub>2</sub> sensitivity across the entire brain.</p>
<p>Our data from three independent assays (dye loading, measurement of ATP release and whole cell recordings) show that hemichannels of Cx43 open to modest changes in PCO<sub>2</sub>. However, Cx43 gap junction channels are insensitive to these same changes in PCO<sub>2</sub>. At physiological levels of PCO<sub>2</sub> Cx43 hemichannels are partially open and able to release ATP. This observation potentially resolves a puzzling inconsistency in the literature. Many biophysical recordings of Cx43 hemichannels, performed in simplified buffered salines without appreciable dissolved CO<sub>2</sub> or HCO<sub>3-</sub>, document Cx43 hemichannels as being shut (<xref ref-type="bibr" rid="c6">Contreras <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="c48">Schalper <italic>et al</italic>., 2010</xref>). By contrast, under physiological conditions both <italic>in vitro</italic> and <italic>in vivo</italic>, which necessarily involve CO<sub>2</sub>-HCO<sub>3-</sub>buffering, the evidence suggests that Cx43 hemichannels remain open to some extent (<xref ref-type="bibr" rid="c4">Chever <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="c21">Guillebaud <italic>et al</italic>., 2020</xref>; <xref ref-type="bibr" rid="c55">Turovsky <italic>et al</italic>., 2020</xref>). Continual ATP release from astrocytes via Cx43 has been shown to give a tone of ATP that enhances the strength of synaptic transmission in the hippocampus by about 20% (<xref ref-type="bibr" rid="c4">Chever <italic>et al</italic>., 2014</xref>). Our data is highly complementary to these observations as we find an enhancement of fEPSP amplitude of about 30% when increasing PCO<sub>2</sub> from 20 to 35 mmHg. It is important to note that our experiments were performed under isohydric conditions and differ from a prior study that examined hypocapnia with simultaneous alkalinisation. This manipulation enhanced fEPSP strength through a reduction in extracellular adenosine and consequently less inhibition via A1 receptors (<xref ref-type="bibr" rid="c16">Dulla <italic>et al</italic>., 2005</xref>).</p>
<p>While our data suggests that Cx43 hemichannels are sensitive to PCO<sub>2</sub> over the range 20-70 mmHg, there is an indication that there may be some CO<sub>2</sub>-dependent inhibition of hemichannel opening above 55 mmHg. Slightly less ATP release was consistently seen at a PCO<sub>2</sub> of 70 mmHg compared to 55 mmHg. Furthermore, we cannot be sure that Cx43 hemichannels are completely shut at a PCO<sub>2</sub> of 20 mmHg, as it is not possible to reduce the PCO<sub>2</sub> further without changing to HEPES buffered salines. That Gap26 reduced synaptic transmission below the baseline amplitude recorded in slices bathed in 20 mmHg aCSF suggests that even under this condition there may still be a low level of Cx43 hemichannel gating at least in neural tissue which will continually generate CO<sub>2</sub> via oxidative phosphorylation.</p>
<p>Cx43 gap junction channels and hemichannels are closed by intracellular acidification. This involves interaction between the C-terminus and the cytoplasmic loop (<xref ref-type="bibr" rid="c15">Duffy <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="c22">Hirst-Jensen <italic>et al</italic>., 2007</xref>). Similar interactions between the C-terminus and cytoplasmic loop are involved in regulating hemichannel activity stimulated by increases in intracellular Ca<sup>2+</sup> (<xref ref-type="bibr" rid="c25">Iyyathurai <italic>et al</italic>., 2018</xref>). However, the CO<sub>2</sub> dependent opening of Cx43 is independent of these mechanisms as it persists when the C-terminus has been deleted.</p>
</sec>
<sec id="s3b">
<title>The residues involved in CO<sub>2</sub> sensitivity and possible mechanisms</title>
<p>By exploiting the new structural data for connexins (<xref ref-type="bibr" rid="c38">Myers <italic>et al</italic>., 2018</xref>; <xref ref-type="bibr" rid="c18">Flores <italic>et al</italic>., 2020</xref>; <xref ref-type="bibr" rid="c30">Lee <italic>et al</italic>., 2020</xref>; <xref ref-type="bibr" rid="c62">Yue <italic>et al</italic>., 2021</xref>; <xref ref-type="bibr" rid="c2">Brotherton <italic>et al</italic>., 2022</xref>; <xref ref-type="bibr" rid="c45">Qi <italic>et al</italic>., 2022</xref>; <xref ref-type="bibr" rid="c31">Lee <italic>et al</italic>., 2023a</xref>; <xref ref-type="bibr" rid="c32">Lee <italic>et al</italic>., 2023b</xref>; <xref ref-type="bibr" rid="c44">Qi <italic>et al</italic>., 2023</xref>), the predictive power of AF3 and our understanding of carbamylation and CO<sub>2</sub>-dependent gating of Cx26 hemichannels and GJCs (<xref ref-type="bibr" rid="c42">Nijjar <italic>et al</italic>., 2021</xref>; <xref ref-type="bibr" rid="c1">Brotherton <italic>et al</italic>., 2024</xref>), we identified a series of residues that could plausibly be involved in mediating the CO<sub>2</sub> sensitivity of Cx43: K144, the equivalent of K125 in Cx26; K105, the analogue of R104 in Cx26; K109, the equivalent of K108 in Cx26; and K234, an equivalent of R216 in Cx26. Both K125 and K108 in Cx26 are known to be carbamylated (<xref ref-type="bibr" rid="c41">Nijjar <italic>et al</italic>., 2025</xref>). Carbamylation of K125 is essential for hemichannel opening to CO<sub>2</sub>, whereas carbamylation of both K125 and K108 is required for GJC closure to CO<sub>2</sub> (<xref ref-type="bibr" rid="c41">Nijjar <italic>et al</italic>., 2025</xref>). R216 in Cx26 has been tentatively identified as a possible interacting partner for K108 but this could be indirect (<xref ref-type="bibr" rid="c41">Nijjar <italic>et al</italic>., 2025</xref>). Crucially the spatial arrangements of K144, K105, K109 and K234 in AF3 predictions indicate that these residues are sufficiently close to interact across the subunit boundary.</p>
<p>In Cx26, K125 is proposed to interact with R104 following carbamylation, and interestingly mutation of either K125 or R104 is sufficient to abolish CO<sub>2</sub> dependent hemichannel opening and GJC closure. Mutation of K108 is also sufficient by itself to abolish GJC closure to CO<sub>2</sub> (<xref ref-type="bibr" rid="c41">Nijjar <italic>et al</italic>., 2025</xref>). By contrast single mutations to Gln of any of the 4 Lys residues identified in Cx43 as the equivalents to those involved in CO<sub>2</sub>-dependent gating of Cx26 were unable to completely abolish CO<sub>2</sub> sensitivity. Similarly the mutations K125E and R104E in Cx26 create consitutively open hemichannels. However single Lys to Glu mutations in Cx43 did not have this effect. Our data show that in Cx43 at least 2 of the 4 identified residues must be mutated to completely abolish CO<sub>2</sub> sensitivity or to give constitutively open hemichannels. For example mutation of any two Lys residues to Gln, completely abolishes CO<sub>2</sub> dependent ATP release and dye loading. Conversely the double mutation, K105E and K109E, is required for constitutively open hemichannels.</p>
<p>This suggests that in Cx43 there is some redundancy in the effect of CO<sub>2</sub>. One possible interpretation is that two carbamate bridges are formed: one being between K144 and K105 (the direct equivalent of K125-R104 in Cx26); and the second being between K109 and K234. There is certainly some data that support this: the double mutations K109Q-K144Q, K105Q-K234Q and K144Q-K234Q being completely insensitive to CO<sub>2</sub>. These double mutations would remove both of the proposed bridges. However our observation that the mutations K105Q-K144Q, K109Q-K234Q also completely remove CO<sub>2</sub> sensitivity is inconsistent with a simple two bridge hypothesis as these double mutations would only affect one of the bridges and should therefore leave the other intact to give some degree of CO<sub>2</sub> sensitivity. Instead, we favour a hypothesis in which any of these four residues could be carbamylated but that they all have potential to interact. Depending on which residues become carbamylated a bridge could form between K105 and K234 or between K109 and K144, and possibly even K144 and K234. There is some support for this idea from AF3 as K105 and K109 are only one turn distant in an alpha helix and both could therefore interact with either K144 or K234 following carbamylation. The residues in Cx43 that are involved in CO<sub>2</sub> sensitivity are equivalent to those identified in Cx26, where they participate in both hemichannel and gap junction channel gating to CO<sub>2</sub>. However in Cx43 these residues are only involved in mediating the sensitivity of the hemichannel to CO<sub>2</sub>. In this respect it is interesting that mutations of the different Lys residues alter the dose-sensitivity of Cx43 to CO<sub>2</sub> in different ways (<xref rid="fig4_S1" ref-type="fig">Fig 4, figure supplement 1</xref>). New cryo-EM studies of Cx43 hemichannels at vitrified different levels of PCO<sub>2</sub> would shed more light on the mechanism of opening,</p>
</sec>
<sec id="s3c">
<title>Physiological implications of the CO<sub>2</sub> sensitivity of Cx43</title>
<p>Cx43 is the most widely expressed connexin in the human body, being present in every organ system (<xref ref-type="bibr" rid="c34">Lucaciu <italic>et al</italic>., 2023</xref>). In metabolically highly active organs such as liver, kidney and brain, our data suggest that the physiological PCO<sub>2</sub> will be sufficient to substantially open Cx43 hemichannels (<xref ref-type="bibr" rid="c23">Hogg <italic>et al</italic>., 1984</xref>). In the context of the brain, Cx43 is the main astrocytic connexin and is expressed in all subtypes of astrocytes (<xref ref-type="bibr" rid="c10">de Ceglia <italic>et al</italic>., 2023</xref>). This would imply that CO<sub>2</sub>-sensitivity mediated via Cx43 will extend to potentially all brain regions. As astrocytes are non-excitable, they are unlikely to become sufficiently depolarised for Cx43 hemichannels to open via voltage dependent gating. We suggest therefore, in non-excitable cells such as astrocytes, that variations in PCO<sub>2</sub> may be the most important physiological regulator of Cx43 hemichannel gating. For astrocytes, CO<sub>2</sub>-dependent opening of Cx43 hemichannels is likely to result in the release of a mix of small, neurochemically significant molecules such as ATP, glutamate, D-serine and lactate, depending on their intracellular concentration.</p>
<p>Cx43 is also highly expressed in the heart, if a proportion of the population were to be in hemichannel form as opposed to GJCs (<xref ref-type="bibr" rid="c11">De Smet <italic>et al</italic>., 2021</xref>), the newly-discovered CO<sub>2</sub> sensitivity of hemichannels may have profound implications for heart function given that cardiomyocytes are highly active, and will thus generate high levels of CO<sub>2</sub> through oxidative phosphorylation. There is a long-established link between CO<sub>2</sub> and cardiac function with effects such as increased coronary blood flow in response to CO<sub>2</sub> as well as changes in myocardial contractile function (<xref ref-type="bibr" rid="c8">Crystal, 2015</xref>). CO<sub>2</sub> can even cause arrythmias (<xref ref-type="bibr" rid="c63">Zhang <italic>et al</italic>., 2019</xref>). The effects of CO<sub>2</sub> may be mediated through changes in intracellular pH, which is well known to alter the function of cardiac myocytes (<xref ref-type="bibr" rid="c52">Spitzer <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="c57">Vaughan-Jones <italic>et al</italic>., 2009</xref>; <xref ref-type="bibr" rid="c43">Orlowski <italic>et al</italic>., 2025</xref>). However, given that Cx43 is directly sensitive to CO<sub>2</sub>, an investigation as to whether CO<sub>2</sub> also has direct effects on cardiac function that are independent of consequent changes in intracellular pH seems warranted.</p>
<p>NF-kappa B and innate immunity exhibit sensitivity to CO<sub>2</sub> (<xref ref-type="bibr" rid="c9">Cummins <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="c27">Keogh <italic>et al</italic>., 2017</xref>). Macrophages are CO<sub>2</sub>-sensitive, although at least some of this is indirect and via pH changes mediated by carbonic anhydrase activity (<xref ref-type="bibr" rid="c54">Strowitzki <italic>et al</italic>., 2022</xref>). However, a direct effect of CO<sub>2</sub> on components of the immune system cannot be excluded. In cell culture, when carbonic anhydrase activity is blocked in THP-1 monocytes, the effects of CO<sub>2</sub> are significantly diminished but not abolished, suggesting the existence of a pH-independent pathway (<xref ref-type="bibr" rid="c54">Strowitzki <italic>et al</italic>., 2022</xref>). As Cx43 is expressed in monocytes it is a plausible candidate to mediate direct CO<sub>2</sub> sensitivity in these cells. Furthermore, Cx43 function in macrophages is deemed critical for various physiological and pathophysiological processes (<xref ref-type="bibr" rid="c47">Rodjakovic <italic>et al</italic>., 2021</xref>). The role of CO<sub>2</sub> on such pathways remains to be explored.</p>
<p>It is interesting that pathological mutations of Cx43 abrogate CO<sub>2</sub> sensitivity. This follows a pattern seen for Cx26, where a range of mutations linked to syndromic and non-syndromic hearing loss (<xref ref-type="bibr" rid="c36">Meigh <italic>et al</italic>., 2014</xref>; <xref ref-type="bibr" rid="c13">de Wolf <italic>et al</italic>., 2016</xref>; <xref ref-type="bibr" rid="c7">Cook <italic>et al</italic>., 2019</xref>), and for Cx32, where several mutations that cause X-linked Charcot Marie Tooth Disease (<xref ref-type="bibr" rid="c3">Butler &amp; Dale, 2023</xref>) alter or completely block CO<sub>2</sub> sensitivity. Further studies are needed to see whether loss of CO<sub>2</sub> sensitivity from Cx43 does indeed contribute to pathology.</p>
</sec>
<sec id="s3d">
<title>Evolution of CO<sub>2</sub> sensitivity in connexins</title>
<p>Our previous findings showed that a common carbamylation motif is prevalent across the beta-connexin clade and confers CO<sub>2</sub>-sensitivity on the connexins that possess it (<xref ref-type="bibr" rid="c14">Dospinescu <italic>et al</italic>., 2019</xref>). This motif for example is present in shark Cx32 (which is CO<sub>2</sub> sensitive). Humans and sharks last shared a common ancestor about 400-450 MYA. Our discovery that a very similar carbamylation motif is present in Cx43 and confers CO<sub>2</sub> sensitivity onto their hemichannels. Examining the sequences of other human and non-human alpha connexins reveals that the carbamylation motif with appropriately oriented residues is present in human Cx50, Cx59 and Cx62 as well as Cx40, Cx46 and Cx57 of non-human species (<xref rid="fig12" ref-type="fig">Fig 12</xref>, <xref rid="fig12" ref-type="fig">Fig 12</xref> Table Supplement). We have shown Cx50 hemichannels are CO<sub>2</sub> sensitive and this also depends on the carbamylation motif (<xref ref-type="bibr" rid="c33">Lovatt <italic>et al</italic>., 2025</xref>). These findings suggest that the carbamylation motif and CO<sub>2</sub> sensitivity must have been present in the ancestral connexin gene that predated the establishment of the alpha and beta connexin clades. Further work is needed to understand the evolution of the carbamylation motif and CO<sub>2</sub> sensitivity, but our observations indicate that it is an ancient feature within the molecular phylogeny of the connexins, rather than being a more recently derived feature restricted to the beta connexins.</p>
<fig id="fig12" position="float" fig-type="figure">
<label>Figure 12:</label>
<caption><title>Occurrence of the carbamylation motif in the alpha connexin clade.</title>
<p>Names in red indicate the presence of the motif. The sequences were aligned in TCoffee to check for the presence of the motif. The molecular phylogenetic tree was constructed from the aligned traces by the average distance using Blosum62 in JalView (<xref ref-type="bibr" rid="c59">Waterhouse <italic>et al</italic>., 2009</xref>). Accession numbers for the protein sequences in the tree are given in the accompanying table supplement.</p></caption>
<graphic xlink:href="632711v2_fig12.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</sec>
<sec id="s4">
<title>Methods</title>
<sec id="s4a">
<title>Recording Solutions</title>
<p>Hypocapnic (20 mmHg PCO<sub>2</sub>): 140 mM NaCl, 10 mM NaHCO<sub>3</sub>, 1.25 mM NaH<sub>2</sub>PO<sub>4</sub>, 3mM KCl, 1 mM MgSO<sub>4</sub>, 10 mM D-glucose and 2 mM CaCl<sub>2</sub>. This was bubbled with a mix of 95%O<sub>2</sub>/5%CO<sub>2</sub> and balanced with sufficient pure O<sub>2</sub> from an oxygen concentrator to give a final pH of ~7.3.</p>
<p>Control (35 mmHg PCO<sub>2</sub>): 124 mM NaCl, 26 mM NaHCO<sub>3</sub>, 1.25 mM NaH<sub>2</sub>PO<sub>4</sub>, 3 mM KCl, 10 mM D-glucose, 1 mM MgSO<sub>4</sub>, 2 mM CaCl<sub>2</sub>. This was bubbled with 95%O<sub>2</sub>/5% CO<sub>2</sub> and had a final pH of ~7.3.</p>
<p>Hypercapnic (55 mmHg PCO<sub>2</sub>): 100 mM NaCl, 50 mM NaHCO<sub>3</sub>, 1.25 mM NaH<sub>2</sub>PO<sub>4</sub>, 3 mM KCl, 10 mM D-glucose, 1 mM MgSO<sub>4</sub>, 2 mM CaCl<sub>2</sub>. This was bubbled with sufficient CO<sub>2</sub> (~9%, balance O<sub>2</sub>) to give a final pH of ~7.3.</p>
<p>Hypercapnic (70 mmHg PCO<sub>2</sub>): 73 mM NaCl, 80 mM NaHCO<sub>3</sub>, 1.25 mM NaH<sub>2</sub>PO<sub>4</sub>, 3 mM KCl, 10 mM D-glucose, 1 mM MgSO<sub>4</sub>, 2 mM CaCl<sub>2</sub>. This was bubbled with sufficient CO<sub>2</sub> (approximately 12%, balance O<sub>2</sub>) to give a final pH of ~7.3.</p>
<p>Zero Ca<sup>2+</sup>: 140 mM NaCl, 10 mM NaHCO<sub>3</sub>, 1.25 mM NaH<sub>2</sub>PO<sub>4</sub>, 3mM KCl, 1 mM MgSO<sub>4</sub>. On the day of recording, 10 mM D-glucose, 1 mM EGTA (Ethyleneglycol-bis(β-aminoethyl)-N,N,N',N'-tetraacetic acid) and 2 mM MgCl<sub>2</sub> was added, and the solution bubbled with 95%O<sub>2</sub>/5%CO<sub>2</sub> and balanced with sufficient pure O<sub>2</sub> from an oxygen concentrator to give a final pH of ~7.3.</p>
</sec>
<sec id="s4b">
<title>Cloning and mutagenesis</title>
<p>Plasmids containing mutated versions of Cx43 were generated using the Gibson Assembly method (<xref ref-type="bibr" rid="c20">Gibson <italic>et al</italic>., 2009</xref>). Overlapping fragments both containing the desired mutation were PCR amplified with primers. Double mutations were cloned using successive Gibson assemblies. PCR fragments were amplified using Q5® High-Fidelity DNA Polymerase (New England Biolabs) (normal PCR or site-directed mutagenesis). The overlap region generated through PCR for Gibson Assembly was 20 base pairs, and the pCAG vector was used as the backbone. All Cx43 constructs were inserted upstream of an mCherry tag, linked via a 12 AA linker (GVPRARDPPVAT). All PCR primers were purchased from Integrated DNA Technologies (IDT). For double mutations, an additional round of cloning was performed using a single mutant as the template, to introduce the additional mutation. For the truncation (Cx43<sup>1-256</sup>), we created a PCR product of the truncated version of Cx43 and fused it to the same AA linker and mCherry as previously stated, to allow visualisation of cellular localisation. All constructs were confirmed by DNA sequencing (Eurofins GATC sequencing or Plasmidasaurus).</p>
</sec>
<sec id="s4c">
<title>Cell culture</title>
<p>HeLa DH cells were grown in Dulbecco’s Modified Eagle Medium (DMEM), supplemented with 10% fetal bovine serum, 50 μg/mL penicillin/streptomycin. HeLa DH cells were used for patch clamp studies on Cx43 and for the dye loading of all Cx43 variants. For dye loading experiments, cells were seeded onto coverslips at a density of 7.5 × 10<sup>4</sup> cells per well and transiently transfected with the Cx43 constructs following the PEI Transfection Reagent protocol.</p>
</sec>
<sec id="s4d">
<title>Dye-loading</title>
<p>Cell expressing the construct (48-72h) were given an initial 5-minute wash with baseline solution (artificial cerebrospinal fluid – aCSF, 20 mmHg PCO<sub>2</sub>). Following this, the cells were exposed to either control solution, hypercapnic (70 mmHg PCO<sub>2</sub>), or a zero Ca<sup>2+</sup> positive control (20 mmHg PCO<sub>2</sub>) solution, all of which contained 200 µM 5(6)-carboxyfluorescein (CBF) for 10 min. Next, cells were put into 20 mmHg PCO<sub>2</sub> solution with 200 µM CBF for 5 minutes to close any open channels and prevent dye loss in the next step. Then the coverslip was washed with control solution (without CBF) for another 30 min to remove extracellular dye. For each condition a different coverslip with HeLa cells was used. Cx43 was tagged with mCherry on the C-terminus using a short linker. Expression was verified using mCherry fluorescence. The experiments were replicated using independent transfections 5 times.</p>
<p>Following dye loading, HeLa cells were imaged by epifluorescence (Scientifica Slice Scope, Cairn Research OptoLED illumination, 60x water Olympus immersion objective, NA 1.0, Hamamatsu ImagEM EM-CCD camera, Metafluor software). CBFwas excited by a 470 nm LED, with emission captured between 504-543 nm. Cx43 constructs had a C-terminal mCherry tag, which was excited by a 535 nm LED and emission captured between 570-640 nm.</p>
<p>Following acquisition analysis was performed by a person blind to the experimental condition. ImageJ (Wayne Rasband, National Institutes of Health, USA) was used to measure the extent of dye loading by drawing a region of interest (ROI) around each cell, and subsequently, the mean pixel intensity of the ROI was determined. The mean pixel intensity of a representative background ROI for each image was subtracted from each cell measurement from the same image. At least 40 cells were measured for each condition per experiment, and five repetitions of independently transfected HeLa cells were completed. The mean pixel intensities were plotted as cumulative probability distributions, and these graphs show every data point measured. To assess the effect of the 70 mmHg and zero Ca<sup>2+</sup> solutions on dye loading, the difference in the median pixel intensities between the 70mmHg and 20 mmHg conditions, and the zero Ca<sup>2+</sup> and 20 mmHg conditions was calculated for each transfection (<xref rid="fig3" ref-type="fig">Figs 3</xref>, <xref rid="fig5" ref-type="fig">5</xref>, <xref rid="fig7" ref-type="fig">7</xref> and <xref rid="fig11" ref-type="fig">11</xref>).</p>
</sec>
<sec id="s4e">
<title>GRAB<sub>ATP</sub> recordings</title>
<p>Cells were transiently transfected with the pCAG-Cx43-mCherry construct and pDisplay-GRAB_ATP1.0-IRES-mCherry-CAAX (Addgene plasmid # 167582; <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:RRID:Addgene_167582">RRID:Addgene_167582</ext-link>) (<xref ref-type="bibr" rid="c60">Wu <italic>et al</italic>., 2022</xref>) 48 hours prior to imaging. Cells were perfused with control aCSF until a stable baseline was reached, before perfusion with either hypercapnic or high K<sup>+</sup> aCSF (positive control). Once a stable baseline was reached after solution change, cells were again perfused with control aCSF and when a stable baseline reached, recordings were calibrated by direct application of 3 μM of the corresponding analyte.</p>
<p>All cells were imaged by epifluorescence as above. The cpGFP in GRAB<sub>ATP</sub> was excited by a 470 nm LED, with emission captured between 504-543 nm. As the Cx43 constructs were mCherry tagged, we selected only cells that expressed both cpGFP and mCherry for recording. GRAB<sub>ATP</sub> fluorescence images were acquired every 4 seconds. For each condition, at least 3 independent transfections were performed with at least 2 coverslips per transfection.</p>
<p>Analysis of all experiments was carried out in ImageJ. Images were opened as a stack and stabilised. ROIs were drawn around cells co-expressing both sensor and connexin. Median pixel intensity was plotted as normalised fluorescence change (ΔF/F<sub>0</sub>) over time to give traces of fluorescence change. Amount of ATP release was quantified as concentration by normalising to the ΔF/F<sub>0</sub> caused by application of 3 μM ATP.</p>
</sec>
<sec id="s4f">
<title>Intracellular pH measurement</title>
<p>BCECF-AM dissolved in DMSO and Pluronic f127 and diluted in 35 mmHg aCSF for a final concentration of 2 μM. Coverslips seeded with parental HeLa DH cells were incubated in BCECF for 20 minutes, before being washed in 35 mmHg aCSF for 10 minutes. Cells were perfused with control aCSF until a stable baseline was reached, before perfusion with either 55 mmHg or 70 mmHg aCSF. Once a stable baseline was reached after solution change, cells were again perfused with control aCSF. pH<sub>i</sub> was then calibrated following the method in (<xref ref-type="bibr" rid="c26">James-Kracke, 1992</xref>). All cells were imaged by epifluorescence with the BCECF excited by a 470 nm LED and emission captured between 504-543 nm. Measurements were obtained from 3 independent transfections were performed with at least 2 coverslips per transfection.</p>
</sec>
<sec id="s4g">
<title>Patch clamp recordings</title>
<p>Coverslips containing non-confluent HeLa cells were placed into a perfusion chamber at room temperature and superfused with control aCSF. An Axopatch 200B amplifier was used to make whole-cell recordings from single HeLa cells. The intracellular fluid in the patch pipettes contained: K-gluconate 60 mM, Cs-gluconate 50 mM, CsCl 10 mM, TEACl 10 mM, EGTA 10 mM, Na<sub>2</sub>ATP 3mM, MgCl<sub>2</sub> 3 mM, CaCl<sub>2</sub> 1 mM, HEPES 10 mM, sterile filtered, pH adjusted to 7.2 with KOH. An agarose salt bridge was used to avoid solution changes altering the potential of the Ag/AgCl reference electrode. All whole-cell recordings were performed at a holding potential of −50 mV. Whole-cell conductance was measured by repeated steps to −40 mV. To allow for any drift in whole-cell conductance unrelated to the CO<sub>2</sub> stimulus, the maximal conductance during the CO<sub>2</sub> test stimulus was compared to the average of the conductance before the stimulus and after the stimulus had been fully washed off. Each whole cell recording was considered to be an independent statistical replicate.</p>
<p>Control (35 mmHg) aCSF was used as the baseline and switched to 20 mmHg, 55 mmHg or 70 mmHg aCSF to measure the conductance responses to differing levels of PCO<sub>2</sub>. To convert these responses to a PCO<sub>2</sub> dose response curve, assigned a value of zero to 20 mmHg and plotted all changes relative to this. Thus, the values at 35 mmHg were the absolute values of the changes evoked by going from 35 to 20 mmHg, and the absolute value of median change from 35 to 20 mmHg was added to the changes observed going from 35 to 55 and 35 to 70 mmHg.</p>
</sec>
<sec id="s4h">
<title>Imaging assay of gap junction transfer</title>
<p>2-Deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose, NBDG, was included at 200 µM in the patch recording fluid, which contained: K-gluconate 130 mM; KCl 10 mM; EGTA 5 mM; CaCl<sub>2</sub> 2 mM, HEPES 10 mM, pH was adjusted to 7.3 with KOH to give a resulting final osmolarity of 295 mOsm. Cells were imaged on a Cleverscope (MCI Neuroscience) with a Photometrics Prime camera under the control of Micromanager 1.4 software. LED illumination (Cairn Research) and an image splitter (Optosplit, Cairn Research) allowed simultaneous imaging of the mCherry-tagged Cx43 subunits and the diffusion of the NBDG into and between cells. Coupled cells for intercellular dye transfer experiments were initially selected based on tagged Cx43 protein expression and the presence of a gap junctional plaque (<xref rid="fig4_S1" ref-type="fig">Figure 4, figure supplement 1</xref>). Dye permeation between cells was measured at PCO<sub>2</sub> levels of 20, 55 and 70 mmHg. After establishing the whole cell mode of recording, images were collected every 10 seconds. The assay was performed as described by Nijjar et al (<xref ref-type="bibr" rid="c42">Nijjar <italic>et al</italic>., 2021</xref>). The start of recording was taken to be the first image following the establishment of a stable whole cell recording. For each gap junction recording (considered as an independent statistical replicate), analysis of the cell images was performed in ImageJ using an ROI drawn on each cell to measure the median pixel intensity of the donor and acceptor cells. The time for the median fluorescence of the acceptor cell to reach 10% of the donor cell was then determined and used as the value for statistical comparisons.</p>
</sec>
<sec id="s4i">
<title>Hippocampal slice preparation</title>
<p>Mice of either sex, 3-5 weeks old, were killed by cervical dislocation and decapitated in accordance with United Kingdom Animals (Scientific Procedures) Act (1986). The brain was dissected and kept on ice both the cerebellum and the rostral section of the brain were removed. 400 µm thick sagittal slices were cut with a vibratome (Microm HM 650V microsliver) in ice-cold cutting solution composed of (in mM: 85 NaCl, 2.5 KCl, 0.5 CaCl<sub>2</sub>, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 24 NaHCO<sub>3</sub>, 25 glucose, and 75 sucrose; pH was adjusted to 7.4, bubbled with 95% O<sub>2</sub> + 5% CO<sub>2</sub>). Then slices were incubated in aCSF composed of (in mM: 127 NaCl, 1.9 KCl, 2 MgCl<sub>2</sub>, 2 CaCl<sub>2</sub>, 1.2 KH<sub>2</sub>PO<sub>4</sub>, 26 NaHCO<sub>3</sub>, 10 D-glucose, pH 7.4, when bubbled with 95% O<sub>2</sub> and 5% CO<sub>2</sub>) at 33 °C. For fEPSP recordings an individual slice was pre-incubated in 20 mmHg PCO<sub>2</sub> aCSF for 30 mins, following which the slice was transferred to a recording chamber submerged in aCSF at 32°C. For stimulation, pulses were delivered by a stimulator via concentric bipolar metal stimulating electrode placed on the surface of CA3. For extracellular recordings, an aCSF-filled microelectrode was placed in CA1.</p>
</sec>
<sec id="s4j">
<title>Statistics</title>
<p>Data is plotted as either cumulative probabilities (showing every data point) or box and whisker plots where the box is interquartile rage, bar is median, and whisker extends to most extreme data point that is no more than 1.5 times the interquartile range. All individual data points are superimposed on the plots.</p>
<p>In the case of dye loading one transfection was considered one replicate. In the case of patch clamping and GRAB<sub>ATP</sub> experiments, one cell was considered one replicate. For dye-loading, to assess the effect a mutation would have on the protein, the difference in dye loading evoked by 70 mmHg PCO<sub>2</sub> or 0 Ca<sup>2+</sup> conditions (from the 20 mmHg baseline) for each construct were compared, using the median value for each condition from each transfection. The Mann-Whitney U one-sided test was used for the comparison on the basis that <italic>a priori</italic> we expected mutations to either reduce CO<sub>2</sub> sensitivity or have no effect. To compare the fEPSP size across different conditions, the non-parametric Friedman two-way ANOVA was used. Statistical analysis was performed using the python language and SciPy library.</p>
</sec>
<sec id="s4k">
<title>Reagents used</title>
<table-wrap id="utbl1" orientation="portrait" position="float">
<graphic xlink:href="632711v2_utbl1.tif" mimetype="image" mime-subtype="tiff"/>
<graphic xlink:href="632711v2_utbl1a.tif" mimetype="image" mime-subtype="tiff"/>
<graphic xlink:href="632711v2_utbl1b.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
</sec>
</sec>
</body>
<back>
<sec id="das" sec-type="data-availability">
<title>Data availability</title>
<p>All data generated in the paper is available as supplements to the figures.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We thank Prof Alexander Cameron for commenting on a draft of this paper.</p>
</ack>
<sec id="additional-info" sec-type="additional-information">
<title>Additional information</title>
<sec id="s6">
<title>Funding</title>
<p>We thank the BBSRC (BB/T013346/1, ND) for support. JB was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) and University of Warwick funded Midlands Integrative Biosciences Training Partnership (MIBTP) grant number BB/T00746X/1. VMD was funded by the Medical Research Council through the University of Warwick Doctoral Training Partnership, grant number MR/N014294/1.</p>
</sec>
</sec>
<sec id="additional-files" sec-type="supplementary-material">
<title>Additional files</title>
<supplementary-material id="supp1">
<label>Figure 9 movie supplement 1.</label>
<caption>
<title>GRAB<sub>ATP</sub> fluorescence recorded from HeLa cells expressing Cx43<sup>K105E K109E</sup> during application of 100 µM LaCl<sub>3</sub> in 20 mmHg PCO<sub>2</sub> aCSF.</title>
</caption>
<media mimetype="video" mime-subtype="avi" xlink:href="supp1.avi"/>
</supplementary-material>
<supplementary-material id="supp2">
<label>Figure 2—Source data 1.</label>
<media mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="supp2.xlsx"/>
</supplementary-material>
<supplementary-material id="supp3">
<label>Figure 3—Source data 1.</label>
<media mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="supp3.xlsx"/>
</supplementary-material>
<supplementary-material id="supp4">
<label>Figure 4—Source data 1.</label>
<media mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="supp4.xlsx"/>
</supplementary-material>
<supplementary-material id="supp5">
<label>Figure 5—Source data 1.</label>
<media mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="supp5.xlsx"/>
</supplementary-material>
<supplementary-material id="supp6">
<label>Figure 6—Source data 1.</label>
<media mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="supp6.xlsx"/>
</supplementary-material>
<supplementary-material id="supp7">
<label>Figure 7—Source data 1.</label>
<media mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="supp7.xlsx"/>
</supplementary-material>
<supplementary-material id="supp8">
<label>Figure 8—Source data 1.</label>
<media mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="supp8.xlsx"/>
</supplementary-material>
<supplementary-material id="supp9">
<label>Figure 9—Source data 1.</label>
<media mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="supp9.xlsx"/>
</supplementary-material>
<supplementary-material id="supp10">
<label>Figure 10—Source data 1.</label>
<media mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="supp10.xlsx"/>
</supplementary-material>
<supplementary-material id="supp11">
<label>Figure 11—Source data 1.</label>
<media mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="supp11.xlsx"/>
</supplementary-material>
<supplementary-material id="supp12">
<label>Figure 12 Supplementary Table.</label>
<media mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="supp12.xlsx"/>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brotherton</surname>, <given-names>D.H.</given-names></string-name>, <string-name><surname>Nijjar</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Savva</surname>, <given-names>C.G.</given-names></string-name>, <string-name><surname>Dale</surname>, <given-names>N.</given-names></string-name> &amp; <string-name><surname>Cameron</surname>, <given-names>A.D.</given-names></string-name></person-group> (<year>2024</year>) <article-title>Structures of wild-type and a constitutively closed mutant of connexin26 shed light on channel regulation by CO2</article-title>. <source>eLife</source>, <volume>13</volume>, <elocation-id>RP93686</elocation-id>. <pub-id pub-id-type="doi">10.7554/eLife.93686</pub-id></mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brotherton</surname>, <given-names>D.H.</given-names></string-name>, <string-name><surname>Savva</surname>, <given-names>C.G.</given-names></string-name>, <string-name><surname>Ragan</surname>, <given-names>T.J.</given-names></string-name>, <string-name><surname>Dale</surname>, <given-names>N.</given-names></string-name> &amp; <string-name><surname>Cameron</surname>, <given-names>A.D.</given-names></string-name></person-group> (<year>2022</year>) <article-title>Conformational changes and CO2-induced channel gating in connexin26</article-title>. <source>Structure</source>, <volume>30</volume>, <fpage>697</fpage>–<lpage>706</lpage>.</mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Butler</surname>, <given-names>J.</given-names></string-name> &amp; <string-name><surname>Dale</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2023</year>) <article-title>X-linked Charcot Marie Tooth mutations alter CO(2) sensitivity of connexin32 hemichannels</article-title>. <source>Front Cell Neurosci</source>, <volume>17</volume>, <fpage>1330983</fpage>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chever</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>C.Y.</given-names></string-name> &amp; <string-name><surname>Rouach</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2014</year>) <article-title>Astroglial connexin43 hemichannels tune basal excitatory synaptic transmission</article-title>. <source>J Neurosci</source>, <volume>34</volume>, <fpage>11228</fpage>–<lpage>11232</lpage>.</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cocozzelli</surname>, <given-names>A.G.</given-names></string-name> &amp; <string-name><surname>White</surname>, <given-names>T.W.</given-names></string-name></person-group> (<year>2019</year>) <article-title>Connexin 43 Mutations Lead to Increased Hemichannel Functionality in Skin Disease</article-title>. <source>Int J Mol Sci</source>, <volume>20</volume>.</mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Contreras</surname>, <given-names>J.E.</given-names></string-name>, <string-name><surname>Saez</surname>, <given-names>J.C.</given-names></string-name>, <string-name><surname>Bukauskas</surname>, <given-names>F.F.</given-names></string-name> &amp; <string-name><surname>Bennett</surname>, <given-names>M.V.</given-names></string-name></person-group> (<year>2003</year>) <article-title>Gating and regulation of connexin 43 (Cx43) hemichannels</article-title>. <source>Proc Natl Acad Sci U S A</source>, <volume>100</volume>, <fpage>11388</fpage>–<lpage>11393</lpage>.</mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cook</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>de Wolf</surname>, <given-names>E.</given-names></string-name> &amp; <string-name><surname>Dale</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2019</year>) <article-title>Cx26 keratitis ichthyosis deafness syndrome mutations trigger alternative splicing of Cx26 to prevent expression and cause toxicity in vitro</article-title>. <source>Royal Society open science</source>, <volume>6</volume>, <fpage>191128</fpage>.</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Crystal</surname>, <given-names>G.J.</given-names></string-name></person-group> (<year>2015</year>) <article-title>Carbon Dioxide and the Heart: Physiology and Clinical Implications</article-title>. <source>Anesth Analg</source>, <volume>121</volume>, <fpage>610</fpage>–<lpage>623</lpage>.</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cummins</surname>, <given-names>E.P.</given-names></string-name>, <string-name><surname>Oliver</surname>, <given-names>K.M.</given-names></string-name>, <string-name><surname>Lenihan</surname>, <given-names>C.R.</given-names></string-name>, <string-name><surname>Fitzpatrick</surname>, <given-names>S.F.</given-names></string-name>, <string-name><surname>Bruning</surname>, <given-names>U.</given-names></string-name>, <string-name><surname>Scholz</surname>, <given-names>C.C.</given-names></string-name>, <string-name><surname>Slattery</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Leonard</surname>, <given-names>M.O.</given-names></string-name>, <string-name><surname>McLoughlin</surname>, <given-names>P.</given-names></string-name> &amp; <string-name><surname>Taylor</surname>, <given-names>C.T.</given-names></string-name></person-group> (<year>2010</year>) <article-title>NF-kappaB links CO2 sensing to innate immunity and inflammation in mammalian cells</article-title>. <source>J Immunol</source>, <volume>185</volume>, <fpage>4439</fpage>–<lpage>4445</lpage>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de Ceglia</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ledonne</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Litvin</surname>, <given-names>D.G.</given-names></string-name>, <string-name><surname>Lind</surname>, <given-names>B.L.</given-names></string-name>, <string-name><surname>Carriero</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Latagliata</surname>, <given-names>E.C.</given-names></string-name>, <string-name><surname>Bindocci</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Di Castro</surname>, <given-names>M.A.</given-names></string-name>, <string-name><surname>Savtchouk</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Vitali</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Ranjak</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Congiu</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Canonica</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Wisden</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Harris</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Mameli</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Mercuri</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Telley</surname>, <given-names>L.</given-names></string-name> &amp; <string-name><surname>Volterra</surname>, <given-names>A.</given-names></string-name></person-group> (<year>2023</year>) <article-title>Specialized astrocytes mediate glutamatergic gliotransmission in the CNS</article-title>. <source>Nature</source>, <volume>622</volume>, <fpage>120</fpage>–<lpage>129</lpage>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>De Smet</surname>, <given-names>M.A.</given-names></string-name>, <string-name><surname>Lissoni</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Nezlobinsky</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Dries</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Perez-Hernandez</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Amoni</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Vervliet</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Witschas</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Rothenberg</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Bultynck</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Schulz</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Panfilov</surname>, <given-names>A.V.</given-names></string-name>, <string-name><surname>Delmar</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Sipido</surname>, <given-names>K.R.</given-names></string-name> &amp; <string-name><surname>Leybaert</surname>, <given-names>L.</given-names></string-name></person-group> (<year>2021</year>) <article-title>Cx43 hemichannel microdomain signaling at the intercalated disc enhances cardiac excitability</article-title>. <source>The Journal of clinical investigation</source>, <volume>131</volume>.</mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de Wolf</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Cook</surname>, <given-names>J.</given-names></string-name> &amp; <string-name><surname>Dale</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2017</year>) <article-title>Evolutionary adaptation of the sensitivity of connexin26 hemichannels to CO2</article-title>. <source>Proc R Soc B</source>, <volume>284</volume>: <fpage>20162723</fpage>.</mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de Wolf</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>van de Wiel</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Cook</surname>, <given-names>J.</given-names></string-name> &amp; <string-name><surname>Dale</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2016</year>) <article-title>Altered CO2 sensitivity of connexin26 mutant hemichannels in vitro</article-title>. <source>Physiol Rep</source>, <volume>4</volume>, <fpage>e13038</fpage>.</mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dospinescu</surname>, <given-names>V.-M.</given-names></string-name>, <string-name><surname>Nijjar</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Spanos</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Cook</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>de Wolf</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Biscotti</surname>, <given-names>M.A.</given-names></string-name>, <string-name><surname>Gerdol</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Dale</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2019</year>) <article-title>Structural determinants of CO2-sensitivity in the β connexin family suggested by evolutionary analysis</article-title>. <source>Communications Biology</source>, <volume>2</volume>, <fpage>331</fpage>.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Duffy</surname>, <given-names>H.S.</given-names></string-name>, <string-name><surname>Sorgen</surname>, <given-names>P.L.</given-names></string-name>, <string-name><surname>Girvin</surname>, <given-names>M.E.</given-names></string-name>, <string-name><surname>O’Donnell</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Coombs</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Taffet</surname>, <given-names>S.M.</given-names></string-name>, <string-name><surname>Delmar</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Spray</surname>, <given-names>D.C.</given-names></string-name></person-group> (<year>2002</year>) <article-title>pH-Dependent Intramolecular Binding and Structure Involving Cx43 Cytoplasmic Domains*</article-title>. <source>Journal of Biological Chemistry</source>, <volume>277</volume>, <fpage>36706</fpage>–<lpage>36714</lpage>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dulla</surname>, <given-names>C.G.</given-names></string-name>, <string-name><surname>Dobelis</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Pearson</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Frenguelli</surname>, <given-names>B.G.</given-names></string-name>, <string-name><surname>Staley</surname>, <given-names>K.J.</given-names></string-name> &amp; <string-name><surname>Masino</surname>, <given-names>S.A.</given-names></string-name></person-group> (<year>2005</year>) <article-title>Adenosine and ATP link PCO2 to cortical excitability via pH</article-title>. <source>Neuron</source>, <volume>48</volume>, <fpage>1011</fpage>–<lpage>1023</lpage>.</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ek-Vitorín</surname>, <given-names>J.F.</given-names></string-name>, <string-name><surname>Calero</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Morley</surname>, <given-names>G.E.</given-names></string-name>, <string-name><surname>Coombs</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Taffet</surname>, <given-names>S.M.</given-names></string-name> &amp; <string-name><surname>Delmar</surname>, <given-names>M.</given-names></string-name></person-group> (<year>1996</year>) <article-title>PH regulation of connexin43: molecular analysis of the gating particle</article-title>. <source>Biophys J</source>, <volume>71</volume>, <fpage>1273</fpage>–<lpage>1284</lpage>.</mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Flores</surname>, <given-names>J.A.</given-names></string-name>, <string-name><surname>Haddad</surname>, <given-names>B.G.</given-names></string-name>, <string-name><surname>Dolan</surname>, <given-names>K.A.</given-names></string-name>, <string-name><surname>Myers</surname>, <given-names>J.B.</given-names></string-name>, <string-name><surname>Yoshioka</surname>, <given-names>C.C.</given-names></string-name>, <string-name><surname>Copperman</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zuckerman</surname>, <given-names>D.M.</given-names></string-name> &amp; <string-name><surname>Reichow</surname>, <given-names>S.L.</given-names></string-name></person-group> (<year>2020</year>) <article-title>Connexin-46/50 in a dynamic lipid environment resolved by CryoEM at 1.9 A</article-title>. <source>Nat Commun</source>, <volume>11</volume>, <fpage>4331</fpage>.</mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Frenguelli</surname>, <given-names>B.G.</given-names></string-name>, <string-name><surname>Wigmore</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Llaudet</surname>, <given-names>E.</given-names></string-name> &amp; <string-name><surname>Dale</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2007</year>) <article-title>Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus</article-title>. <source>J Neurochem</source>, <volume>101</volume>, <fpage>1400</fpage>–<lpage>1413</lpage>.</mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gibson</surname>, <given-names>D.G.</given-names></string-name>, <string-name><surname>Young</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Chuang</surname>, <given-names>R.Y.</given-names></string-name>, <string-name><surname>Venter</surname>, <given-names>J.C.</given-names></string-name>, <string-name><surname>Hutchison</surname>, <given-names>C.A.</given-names>, <suffix>3rd</suffix></string-name> &amp; <string-name><surname>Smith</surname>, <given-names>H.O.</given-names></string-name></person-group> (<year>2009</year>) <article-title>Enzymatic assembly of DNA molecules up to several hundred kilobases</article-title>. <source>Nat Methods</source>, <volume>6</volume>, <fpage>343</fpage>–<lpage>345</lpage>.</mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guillebaud</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Barbot</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Barbouche</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Brezun</surname>, <given-names>J.M.</given-names></string-name>, <string-name><surname>Poirot</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Vasile</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Lebrun</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Rouach</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Dallaporta</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Gaige</surname>, <given-names>S.</given-names></string-name> &amp; <string-name><surname>Troadec</surname>, <given-names>J.D.</given-names></string-name></person-group> (<year>2020</year>) <article-title>Blockade of Glial Connexin 43 Hemichannels Reduces Food Intake</article-title>. <source>Cells</source>, <volume>9</volume>.</mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hirst-Jensen</surname>, <given-names>B.J.</given-names></string-name>, <string-name><surname>Sahoo</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Kieken</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Delmar</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Sorgen</surname>, <given-names>P.L.</given-names></string-name></person-group> (<year>2007</year>) <article-title>Characterization of the pH-dependent Interaction between the Gap Junction Protein Connexin43 Carboxyl Terminus and Cytoplasmic Loop Domains*</article-title>. <source>Journal of Biological Chemistry</source>, <volume>282</volume>, <fpage>5801</fpage>–<lpage>5813</lpage>.</mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hogg</surname>, <given-names>R.J.</given-names></string-name>, <string-name><surname>Pucacco</surname>, <given-names>L.R.</given-names></string-name>, <string-name><surname>Carter</surname>, <given-names>N.W.</given-names></string-name>, <string-name><surname>Laptook</surname>, <given-names>A.R.</given-names></string-name> &amp; <string-name><surname>Kokko</surname>, <given-names>J.P.</given-names></string-name></person-group> (<year>1984</year>) <article-title>In situ PCO2 in the renal cortex, liver, muscle, and brain of the New Zealand white rabbit</article-title>. <source>Am J Physiol</source>, <volume>247</volume>, <fpage>F491</fpage>–<lpage>498</lpage>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huckstepp</surname>, <given-names>R.T.</given-names></string-name>, <string-name><surname>Eason</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Sachdev</surname>, <given-names>A.</given-names></string-name> &amp; <string-name><surname>Dale</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2010</year>) <article-title>CO2-dependent opening of connexin 26 and related beta connexins</article-title>. <source>J Physiol</source>, <volume>588</volume>, <fpage>3921</fpage>–<lpage>3931</lpage>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Iyyathurai</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>D’hondt</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Jiang</surname>, <given-names>J.X.</given-names></string-name>, <string-name><surname>Leybaert</surname>, <given-names>L.</given-names></string-name> &amp; <string-name><surname>Bultynck</surname>, <given-names>G.</given-names></string-name></person-group> (<year>2018</year>) <article-title>The SH3-binding domain of Cx43 participates in loop/tail interactions critical for Cx43-hemichannel activity</article-title>. <source>Cellular and Molecular Life Sciences</source>, <volume>75</volume>, <fpage>2059</fpage>–<lpage>2073</lpage>.</mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>James-Kracke</surname>, <given-names>M.R.</given-names></string-name></person-group> (<year>1992</year>) <article-title>Quick and accurate method to convert BCECF fluorescence to pHi: calibration in three different types of cell preparations</article-title>. <source>J Cell Physiol</source>, <volume>151</volume>, <fpage>596</fpage>–<lpage>603</lpage>.</mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Keogh</surname>, <given-names>C.E.</given-names></string-name>, <string-name><surname>Scholz</surname>, <given-names>C.C.</given-names></string-name>, <string-name><surname>Rodriguez</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Selfridge</surname>, <given-names>A.C.</given-names></string-name>, von <string-name><surname>Kriegsheim</surname>, <given-names>A.</given-names></string-name> &amp; <string-name><surname>Cummins</surname>, <given-names>E.P.</given-names></string-name></person-group> (<year>2017</year>) <article-title>Carbon dioxide-dependent regulation of NF-kappaB family members RelB and p100 gives molecular insight into CO(2)-dependent immune regulation</article-title>. <source>J Biol Chem</source>, <volume>292</volume>, <fpage>11561</fpage>–<lpage>11571</lpage>.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lai</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Le</surname>, <given-names>D.N.</given-names></string-name>, <string-name><surname>Paznekas</surname>, <given-names>W.A.</given-names></string-name>, <string-name><surname>Gifford</surname>, <given-names>W.D.</given-names></string-name>, <string-name><surname>Jabs</surname>, <given-names>E.W.</given-names></string-name> &amp; <string-name><surname>Charles</surname>, <given-names>A.C.</given-names></string-name></person-group> (<year>2006</year>) <article-title>Oculodentodigital dysplasia connexin43 mutations result in non-functional connexin hemichannels and gap junctions in C6 glioma cells</article-title>. <source>J Cell Sci</source>, <volume>119</volume>, <fpage>532</fpage>–<lpage>541</lpage>.</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Laird</surname>, <given-names>D.W.</given-names></string-name></person-group> (<year>2014</year>) <article-title>Syndromic and non-syndromic disease-linked Cx43 mutations</article-title>. <source>FEBS Lett</source>, <volume>588</volume>, <fpage>1339</fpage>–<lpage>1348</lpage>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname>, <given-names>H.-J.</given-names></string-name>, <string-name><surname>Jeong</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Hyun</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Ryu</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Park</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Lim</surname>, <given-names>H.-H.</given-names></string-name>, <string-name><surname>Yoo</surname>, <given-names>J.</given-names></string-name> &amp; <string-name><surname>Woo</surname>, <given-names>J.-S.</given-names></string-name></person-group> (<year>2020</year>) <article-title>Cryo-EM structure of human Cx31.3/GJC3 connexin hemichannel</article-title>. <source>Science Advances</source>, <volume>6</volume>, <fpage>eaba4996</fpage>.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname>, <given-names>H.J.</given-names></string-name>, <string-name><surname>Cha</surname>, <given-names>H.J.</given-names></string-name>, <string-name><surname>Jeong</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>S.N.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>C.W.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Yoo</surname>, <given-names>J.</given-names></string-name> &amp; <string-name><surname>Woo</surname>, <given-names>J.S.</given-names></string-name></person-group> (<year>2023a</year>) <article-title>Conformational changes in the human Cx43/GJA1 gap junction channel visualized using cryo-EM</article-title>. <source>Nat Commun</source>, <volume>14</volume>, <fpage>931</fpage>.</mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname>, <given-names>S.N.</given-names></string-name>, <string-name><surname>Cho</surname>, <given-names>H.J.</given-names></string-name>, <string-name><surname>Jeong</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Ryu</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>H.J.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Yoo</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Woo</surname>, <given-names>J.S.</given-names></string-name> &amp; <string-name><surname>Lee</surname>, <given-names>H.H.</given-names></string-name></person-group> (<year>2023b</year>) <article-title>Cryo-EM structures of human Cx36/GJD2 neuronal gap junction channel</article-title>. <source>Nat Commun</source>,<volume>14</volume>, <fpage>1347</fpage>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name><surname>Lovatt</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Wijayapala</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Mui</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Butler</surname>, <given-names>J.</given-names></string-name> &amp; <string-name><surname>Dale</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2025</year>) <article-title>Connexin50 hemichannels are opened by CO&amp;lt;sub&amp;gt;2&amp;lt;/sub&amp;gt;: implications for lens physiology</article-title>. <source>bioRxiv</source>, <fpage>2025.2001.2023.634273</fpage>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lucaciu</surname>, <given-names>S.A.</given-names></string-name>, <string-name><surname>Leighton</surname>, <given-names>S.E.</given-names></string-name>, <string-name><surname>Hauser</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Yee</surname>, <given-names>R.</given-names></string-name> &amp; <string-name><surname>Laird</surname>, <given-names>D.W.</given-names></string-name></person-group> (<year>2023</year>) <article-title>Diversity in connexin biology</article-title>. <source>J Biol Chem</source>, <volume>299</volume>, <fpage>105263</fpage>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meigh</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Greenhalgh</surname>, <given-names>S.A.</given-names></string-name>, <string-name><surname>Rodgers</surname>, <given-names>T.L.</given-names></string-name>, <string-name><surname>Cann</surname>, <given-names>M.J.</given-names></string-name>, <string-name><surname>Roper</surname>, <given-names>D.I.</given-names></string-name> &amp; <string-name><surname>Dale</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2013</year>) <article-title>CO2 directly modulates connexin 26 by formation of carbamate bridges between subunits</article-title>. <source>eLife</source>, <volume>2</volume>, <elocation-id>e01213</elocation-id>. <pub-id pub-id-type="doi">10.7554/eLife.01213</pub-id></mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meigh</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Hussain</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Mulkey</surname>, <given-names>D.K.</given-names></string-name> &amp; <string-name><surname>Dale</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2014</year>) <article-title>Connexin26 hemichannels with a mutation that causes KID syndrome in humans lack sensitivity to CO2</article-title>. <source>eLife</source>, <volume>3</volume>, <elocation-id>e04249</elocation-id>. <pub-id pub-id-type="doi">10.7554/eLife.04249</pub-id></mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mikalsen</surname>, <given-names>S.O.</given-names></string-name>, S, Í.K. &amp; <string-name><surname>Tausen</surname>, <given-names>M.</given-names></string-name></person-group> (<year>2021</year>) <article-title>Connexins during 500 Million Years-From Cyclostomes to Mammals</article-title>. <source>Int J Mol Sci</source>, <volume>22</volume>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Myers</surname>, <given-names>J.B.</given-names></string-name>, <string-name><surname>Haddad</surname>, <given-names>B.G.</given-names></string-name>, <string-name><surname>O’Neill</surname>, <given-names>S.E.</given-names></string-name>, <string-name><surname>Chorev</surname>, <given-names>D.S.</given-names></string-name>, <string-name><surname>Yoshioka</surname>, <given-names>C.C.</given-names></string-name>, <string-name><surname>Robinson</surname>, <given-names>C.V.</given-names></string-name>, <string-name><surname>Zuckerman</surname>, <given-names>D.M.</given-names></string-name> &amp; <string-name><surname>Reichow</surname>, <given-names>S.L.</given-names></string-name></person-group> (<year>2018</year>) <article-title>Structure of native lens connexin 46/50 intercellular channels by cryo-EM</article-title>. <source>Nature</source>, <volume>564</volume>, <fpage>372</fpage>–<lpage>377</lpage>.</mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nagy</surname>, <given-names>J.I.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Rempel</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Stelmack</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Patel</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Staines</surname>, <given-names>W.A.</given-names></string-name>, <string-name><surname>Yasumura</surname>, <given-names>T.</given-names></string-name> &amp; <string-name><surname>Rash</surname>, <given-names>J.E.</given-names></string-name></person-group> (<year>2001</year>) <article-title>Connexin26 in adult rodent central nervous system: demonstration at astrocytic gap junctions and colocalization with connexin30 and connexin43</article-title>. <source>J Comp Neurol</source>, <volume>441</volume>, <fpage>302</fpage>–<lpage>323</lpage>.</mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nagy</surname>, <given-names>J.I.</given-names></string-name>, <string-name><surname>Lynn</surname>, <given-names>B.D.</given-names></string-name>, <string-name><surname>Tress</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Willecke</surname>, <given-names>K.</given-names></string-name> &amp; <string-name><surname>Rash</surname>, <given-names>J.E.</given-names></string-name></person-group> (<year>2011</year>) <article-title>Connexin26 expression in brain parenchymal cells demonstrated by targeted connexin ablation in transgenic mice</article-title>. <source>Eur J Neurosci</source>, <volume>34</volume>, <fpage>263</fpage>–<lpage>271</lpage>.</mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nijjar</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Brotherton</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Butler</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Dospinescu</surname>, <given-names>V.M.</given-names></string-name>, <string-name><surname>Gannon</surname>, <given-names>H.G.</given-names></string-name>, <string-name><surname>Linthwaite</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Cann</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Cameron</surname>, <given-names>A.</given-names></string-name> &amp; <string-name><surname>Dale</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2025</year>) <article-title>Multiple carbamylation events are required for differential modulation of Cx26 hemichannels and gap junctions by CO2</article-title>. <source>J Physiol</source>, <volume>603</volume>, <fpage>1071</fpage>–<lpage>1089</lpage>.</mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nijjar</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Maddison</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Meigh</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>de Wolf</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Rodgers</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Cann</surname>, <given-names>M.J.</given-names></string-name> &amp; <string-name><surname>Dale</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2021</year>) <article-title>Opposing modulation of Cx26 gap junctions and hemichannels by CO(2)</article-title>. <source>J Physiol</source>, <volume>599</volume>, <fpage>103</fpage>–<lpage>118</lpage>.</mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Orlowski</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Di Mattia</surname>, <given-names>R.A.</given-names></string-name> &amp; <string-name><surname>Aiello</surname>, <given-names>E.A.</given-names></string-name></person-group> (<year>2025</year>) <article-title>Intracellular pH Regulation in Ventricular Myocytes: Implications for Cardiac Health and Disease</article-title>. <source>Circ Res</source>, <volume>136</volume>, <fpage>1636</fpage>–<lpage>1656</lpage>.</mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Qi</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Acosta Gutierrez</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lavriha</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Othman</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Lopez-Pigozzi</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Bayraktar</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Schuster</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Picotti</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Zamboni</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Bortolozzi</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Gervasio</surname>, <given-names>F.L.</given-names></string-name> &amp; <string-name><surname>Korkhov</surname>, <given-names>V.M.</given-names></string-name></person-group> (<year>2023</year>) <article-title>Structure of the connexin-43 gap junction channel in a putative closed state</article-title>. <source>eLife</source>, <volume>12</volume>.</mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name><surname>Qi</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Acosta-Gutierrez</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lavriha</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Othman</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Lopez-Pigozzi</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Bayraktar</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Schuster</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Picotti</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Zamboni</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Bortolozzi</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Gervasio</surname>, <given-names>F.L.</given-names></string-name> &amp; <string-name><surname>Korkhov</surname>, <given-names>V.M.</given-names></string-name></person-group> (<year>2022</year>) <article-title>Structure of the connexin-43 gap junction channel reveals a closed sieve-like molecular gate</article-title>. <source>bioRxiv</source>, <fpage>2022.2003.2026.485947</fpage>.</mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rash</surname>, <given-names>J.E.</given-names></string-name>, <string-name><surname>Yasumura</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Davidson</surname>, <given-names>K.G.</given-names></string-name>, <string-name><surname>Furman</surname>, <given-names>C.S.</given-names></string-name>, <string-name><surname>Dudek</surname>, <given-names>F.E.</given-names></string-name> &amp; <string-name><surname>Nagy</surname>, <given-names>J.I.</given-names></string-name></person-group> (<year>2001</year>) <article-title>Identification of cells expressing Cx43, Cx30, Cx26, Cx32 and Cx36 in gap junctions of rat brain and spinal cord</article-title>. <source>Cell Commun Adhes</source>, <volume>8</volume>, <fpage>315</fpage>–<lpage>320</lpage>.</mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rodjakovic</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Salm</surname>, <given-names>L.</given-names></string-name> &amp; <string-name><surname>Beldi</surname>, <given-names>G.</given-names></string-name></person-group> (<year>2021</year>) <article-title>Function of Connexin-43 in Macrophages</article-title>. <source>Int J Mol Sci</source>, <volume>22</volume>.</mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schalper</surname>, <given-names>K.A.</given-names></string-name>, <string-name><surname>Sánchez</surname>, <given-names>H.A.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>S.C.</given-names></string-name>, <string-name><surname>Altenberg</surname>, <given-names>G.A.</given-names></string-name>, <string-name><surname>Nathanson</surname>, <given-names>M.H.</given-names></string-name> &amp; <string-name><surname>Sáez</surname>, <given-names>J.C.</given-names></string-name></person-group> (<year>2010</year>) <article-title>Connexin 43 hemichannels mediate the Ca2+ influx induced by extracellular alkalinization</article-title>. <source>American Journal of Physiology-Cell Physiology</source>, <volume>299</volume>, <fpage>C1504</fpage>–<lpage>C1515</lpage>.</mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schulz</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Gorge</surname>, <given-names>P.M.</given-names></string-name>, <string-name><surname>Gorbe</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ferdinandy</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Lampe</surname>, <given-names>P.D.</given-names></string-name> &amp; <string-name><surname>Leybaert</surname>, <given-names>L.</given-names></string-name></person-group> (<year>2015</year>) <article-title>Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection</article-title>. <source>Pharmacol Ther</source>, <volume>153</volume>, <fpage>90</fpage>–<lpage>106</lpage>.</mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shibayama</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Paznekas</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Seki</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Taffet</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Jabs</surname>, <given-names>E.W.</given-names></string-name>, <string-name><surname>Delmar</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Musa</surname>, <given-names>H.</given-names></string-name></person-group> (<year>2005</year>) <article-title>Functional characterization of connexin43 mutations found in patients with oculodentodigital dysplasia</article-title>. <source>Circ Res</source>, <volume>96</volume>, <fpage>e83</fpage>–<lpage>91</lpage>.</mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sohl</surname>, <given-names>G.</given-names></string-name> &amp; <string-name><surname>Willecke</surname>, <given-names>K.</given-names></string-name></person-group> (<year>2004</year>) <article-title>Gap junctions and the connexin protein family</article-title>. <source>Cardiovasc Res</source>, <volume>62</volume>, <fpage>228</fpage>–<lpage>232</lpage>.</mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Spitzer</surname>, <given-names>K.W.</given-names></string-name>, <string-name><surname>Skolnick</surname>, <given-names>R.L.</given-names></string-name>, <string-name><surname>Peercy</surname>, <given-names>B.E.</given-names></string-name>, <string-name><surname>Keener</surname>, <given-names>J.P.</given-names></string-name> &amp; <string-name><surname>Vaughan-Jones</surname>, <given-names>R.D.</given-names></string-name></person-group> (<year>2002</year>) <article-title>Facilitation of intracellular H(+) ion mobility by CO(2)/HCO(3)(-) in rabbit ventricular myocytes is regulated by carbonic anhydrase</article-title>. <source>J Physiol</source>, <volume>541</volume>, <fpage>159</fpage>–<lpage>167</lpage>.</mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Srinivas</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Jannace</surname>, <given-names>T.F.</given-names></string-name>, <string-name><surname>Cocozzelli</surname>, <given-names>A.G.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Slavi</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Sellitto</surname>, <given-names>C.</given-names></string-name> &amp; <string-name><surname>White</surname>, <given-names>T.W.</given-names></string-name></person-group> (<year>2019</year>) <article-title>Connexin43 mutations linked to skin disease have augmented hemichannel activity</article-title>. <source>Sci Rep</source>, <volume>9</volume>, <fpage>19</fpage>.</mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Strowitzki</surname>, <given-names>M.J.</given-names></string-name>, <string-name><surname>Nelson</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Garcia</surname>, <given-names>M.P.</given-names></string-name>, <string-name><surname>Tuffs</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Bleul</surname>, <given-names>M.B.</given-names></string-name>, <string-name><surname>Fitzsimons</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Navas</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Uzieliene</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Ritter</surname>, <given-names>A.S.</given-names></string-name>, <string-name><surname>Phelan</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Kierans</surname>, <given-names>S.J.</given-names></string-name>, <string-name><surname>Blanco</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bernotiene</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Belton</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Schneider</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Cummins</surname>, <given-names>E.P.</given-names></string-name> &amp; <string-name><surname>Taylor</surname>, <given-names>C.T.</given-names></string-name></person-group> (<year>2022</year>) <article-title>Carbon Dioxide Sensing by Immune Cells Occurs through Carbonic Anhydrase 2-Dependent Changes in Intracellular pH</article-title>. <source>J Immunol</source>, <volume>208</volume>, <fpage>2363</fpage>–<lpage>2375</lpage>.</mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Turovsky</surname>, <given-names>E.A.</given-names></string-name>, <string-name><surname>Braga</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Yu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Esteras</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Korsak</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Theparambil</surname>, <given-names>S.M.</given-names></string-name>, <string-name><surname>Hadjihambi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Hosford</surname>, <given-names>P.S.</given-names></string-name>, <string-name><surname>Teschemacher</surname>, <given-names>A.G.</given-names></string-name>, <string-name><surname>Marina</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Lythgoe</surname>, <given-names>M.F.</given-names></string-name>, <string-name><surname>Haydon</surname>, <given-names>P.G.</given-names></string-name> &amp; <string-name><surname>Gourine</surname>, <given-names>A.V.</given-names></string-name></person-group> (<year>2020</year>) <article-title>Mechanosensory Signaling in Astrocytes</article-title>. <source>J Neurosci</source>, <volume>40</volume>, <fpage>9364</fpage>–<lpage>9371</lpage>.</mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>van de Wiel</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Meigh</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Bhandare</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Cook</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Nijjar</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Huckstepp</surname>, <given-names>R.</given-names></string-name> &amp; <string-name><surname>Dale</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2020</year>) <article-title>Connexin26 mediates CO2-dependent regulation of breathing via glial cells of the medulla oblongata</article-title>. <source>Communications Biology</source>, <volume>3</volume>, <fpage>521</fpage>.</mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vaughan-Jones</surname>, <given-names>R.D.</given-names></string-name>, <string-name><surname>Spitzer</surname>, <given-names>K.W.</given-names></string-name> &amp; <string-name><surname>Swietach</surname>, <given-names>P.</given-names></string-name></person-group> (<year>2009</year>) <article-title>Intracellular pH regulation in heart</article-title>. <source>Journal of Molecular and Cellular Cardiology</source>, <volume>46</volume>, <fpage>318</fpage>–<lpage>331</lpage>.</mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wall</surname>, <given-names>M.J.</given-names></string-name> &amp; <string-name><surname>Dale</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2013</year>) <article-title>Neuronal transporter and astrocytic ATP exocytosis underlie activity-dependent adenosine release in the hippocampus</article-title>. <source>J Physiol</source>, <volume>591</volume>, <fpage>3853</fpage>–<lpage>3871</lpage>.</mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Waterhouse</surname>, <given-names>A.M.</given-names></string-name>, <string-name><surname>Procter</surname>, <given-names>J.B.</given-names></string-name>, <string-name><surname>Martin</surname>, <given-names>D.M.</given-names></string-name>, <string-name><surname>Clamp</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Barton</surname>, <given-names>G.J.</given-names></string-name></person-group> (<year>2009</year>) <article-title>Jalview Version 2--a multiple sequence alignment editor and analysis workbench</article-title>. <source>Bioinformatics</source>, <volume>25</volume>, <fpage>1189</fpage>–<lpage>1191</lpage>.</mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>He</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Pan</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Xi</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Deng</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Du</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Jing</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Li</surname>, <given-names>Y.</given-names></string-name></person-group> (<year>2022</year>) <article-title>A sensitive GRAB sensor for detecting extracellular ATP in vitro and in vivo</article-title>. <source>Neuron</source>, <volume>110</volume>, <fpage>770</fpage>–<lpage>782 e775</lpage>.</mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yin</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Feng</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Ma</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Yin</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Hou</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Hao</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Xin</surname>, <given-names>M.</given-names></string-name> &amp; <string-name><surname>Feng</surname>, <given-names>J.</given-names></string-name></person-group> (<year>2018</year>) <article-title>Roles of astrocytic connexin-43, hemichannels, and gap junctions in oxygen-glucose deprivation/reperfusion injury induced neuroinflammation and the possible regulatory mechanisms of salvianolic acid B and carbenoxolone</article-title>. <source>J Neuroinflammation</source>, <volume>15</volume>, <fpage>97</fpage>.</mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yue</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Haddad</surname>, <given-names>B.G.</given-names></string-name>, <string-name><surname>Khan</surname>, <given-names>U.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Atalla</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Zuckerman</surname>, <given-names>D.M.</given-names></string-name>, <string-name><surname>Reichow</surname>, <given-names>S.L.</given-names></string-name> &amp; <string-name><surname>Bai</surname>, <given-names>D.</given-names></string-name></person-group> (<year>2021</year>) <article-title>Connexin 46 and connexin 50 gap junction channel properties are shaped by structural and dynamic features of their N-terminal domains</article-title>. <source>J Physiol</source>, <volume>599</volume>, <fpage>3313</fpage>–<lpage>3335</lpage>.</mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Ma</surname>, <given-names>J.H.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Wei</surname>, <given-names>X.H.</given-names></string-name>, <string-name><surname>Zheng</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>C.Y.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>He</surname>, <given-names>Q.H.</given-names></string-name> &amp; <string-name><surname>Wu</surname>, <given-names>L.</given-names></string-name></person-group> (<year>2019</year>) <article-title>Increase in CO(2) levels by upregulating late sodium current is proarrhythmic in the heart</article-title>. <source>Heart Rhythm</source>, <volume>16</volume>, <fpage>1098</fpage>–<lpage>1106</lpage>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.105989.2.sa4</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Jean X</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution-id institution-id-type="ror">https://ror.org/02f6dcw23</institution-id><institution>The University of Texas Health Science Center at San Antonio</institution>
</institution-wrap>
<city>San Antonio</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Convincing</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Important</kwd>
</kwd-group>
</front-stub>
<body>
<p>This <bold>important</bold> study reveals that connexin43 (Cx43) hemichannels are directly activated by CO₂ through a conserved carbamylation motif, extending a mechanism previously described for β-connexins to α-connexins. The evidence is <bold>convincing</bold>, supported by complementary biochemical and electrophysiological analyses showing CO₂-induced hemichannel opening and ATP release in cultured cells and hippocampal slices. These findings advance our understanding of connexin regulation by metabolic gases and will be of broad interest to researchers studying cell communication, neural signaling, and gasotransmitter biology.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.105989.2.sa3</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>This study builds on previous work demonstrating that several beta connexins (Cx26, Cx30 and Cx32) have a carbamylation motif which renders them sensitive to CO2. In response to CO2, hemichannels composed of these connexins open, enabling diffusion of small molecules (such as ATP) between the cytosol and extracellular environment. Here, the authors have identified that an alpha connexin, Cx43, also contains a carbamylation motif, and they demonstrate that CO2 opens Cx43 hemichannels. Most of the study involves using transfected cells expressing wild-type and mutant Cx43 to define amino acids required for CO2 sensitivity. Hippocampal tissue slices in culture were used to show that CO2-induced synaptic transmission was affected by Cx43 hemichannels, providing a physiological context. The authors point out that the Cx43 gene significantly diverges from the beta connexins that are CO2 sensitive, suggesting that the conserved carbamylation motif was present before the alpha and beta connexin genes diverged.</p>
<p>Strengths:</p>
<p>The molecular analysis defining the amino acids which contribute to the CO2 sensitivity of Cx43 is a major strength of the study. The rigor of analysis was strengthened by using three independent assays for hemichannel opening: dye uptake, patch clamp channel measurements and ATP secretion. The resulting analysis identified key lysines in Cx43 that were required for CO2-mediated hemichannel opening. A double K to E Cx43 mutant produced a construct that produced hemichannels that were constitutively open, which further strengthened the analysis.</p>
<p>Using hippocampal tissue sections to demonstrate that CO2 can influence field excitatory postsynaptic potentials (fEPSPs) provides a native context for CO2 regulation of Cx43 hemichannels. Cx43 mutations associated with Oculodentodigital Dysplasia (ODDD) inhibited CO2-induced hemichannel opening, although the mechanism by which this occurs was not elucidated.</p>
<p>Cytosolic pH was measured and it was further demonstrated that Cx43 hemichannels composed of untagged Cx43 are sensitive to CO2.</p>
<p>A molecular phylogenetic survey was performed which identified several other non-beta connexins that have a putative carbamylation motif. How this relates to connexin evolution was added to the discussion.</p>
<p>Weaknesses:</p>
<p>Cultured cells are typically grown in incubators containing 5% CO2 which is ~40 mmHg. Determining compensatory mechanisms that enable the cells to be viable if Cx43 hemichannels are open at this PCO2 would strengthen the study.</p>
<p>Experiments using Gap26 to inhibit Cx43 hemichannels in fEPSP measurements used a scrambled peptide as a control. Including gap peptides specifically targeting Cx26, Cx30 and Cx32 as additional controls would strengthen the study, since the tissue sections have a complex pattern of connexin expression.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.105989.2.sa2</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>This paper examines the CO2 sensitivity of Cx43 hemichannels and gap junctional channels in transiently transfected Hela cells using several different assays including ethidium dye uptake, ATP release, whole cell patch clamp recordings and an imaging assay of gap junctional dye transfer. The results show that raising pCO2 from 20 to 70 mmHg (at a constant pH of 7.3) cause an increase in opening of Cx43 hemichannels but did not block Cx43 gap junctions. This study also showed that raising pCO2 from 20 to 35 mm Hg resulted in an increase in synaptic strength in hippocampal rat brain slices, presumably due to downstream ATP release, suggesting that the CO2 sensitivity of Cx43 may be physiologically relevant. As a further test of the physiological relevance of the CO2 sensitivity of Cx43, it was shown that two pathological mutations of Cx43 that are associated with ODDD caused loss of Cx43 CO2-sensitivity. Cx43 has a potential carbamylation motif that is homologous to the motif in Cx26. To understand the structural changes involved in CO2 sensitivity, a number of mutations were made in Cx43 sites thought to be the equivalent of those known to be involved in the CO2 sensitivity of Cx26 and the CO2 sensitivity of these mutants was investigated.</p>
<p>Strengths:</p>
<p>This study shows that the apparent lack of functional Cx43 hemichannels observed in a number of previous in vitro function studies may be due to the use of HEPES to buffer the external pH. When Cx43 hemichannels were studied in external solutions in which CO2/bicarbonate was used to buffer pH instead of HEPES, Cx43 hemichannels showed significantly higher levels of dye uptake, ATP release, and ionic conductance. These findings may have major physiological implications since Cx43 hemichannels are found in many organs throughout the body including the brain, heart and immune system.</p>
<p>Weaknesses:</p>
<p>Interpretation of the site-directed mutation studies is complicated. Although Cx43 has a potential carbamylation motif that is homologous to the motif in Cx26, the results of site-directed mutation studies were inconsistent with a simple model in which K144 and K105 interact following carbamylation to cause the opening of Cx43 hemichannels.</p>
<p>Secondly, although it is shown that two Cx43 ODDD associated mutations show a loss of CO2 sensitivity, there is no evidence that the absence of CO2 sensitivity is involved in the pathology of ODDD.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.105989.2.sa1</article-id>
<title-group>
<article-title>Reviewer #3 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>In this paper, authors aimed to investigate carbamylation effects on the function of Cx43-based hemichannels. Such effects have previously been characterized for other connexins, e.g. for Cx26, which display increased hemichannel (HC) opening and closure of gap junction channels upon exposure to increased CO2 partial pressure (accompanied by increased bicarbonate to keep pH constant). The authors used HeLa cells transiently transfected with Cx43 to investigate CO2-dependent carbamylation effects on Cx43 HC function. In contrast to Cx43-based gap junction channels that are here reported to be insensitive to PCO2 alterations, they provide evidence that Cx43 HC opening is highly dependent on the PCO2 pressure in the bath solution, over a range of 20 up to 70 mmHg encompassing the physiologically normal resting level of around 40 mmHg. They furthermore identified several Cx43 residues involved in Cx43 HC sensitivity to PCO2: K105, K109, K144 &amp; K234; mutation of 2 or more of these AAs is necessary to abolish CO2 sensitivity. The subject is interesting and the results indicate that a fraction of HCs is open at a physiological 40 mmHg PCO2, which differs from the situation under HEPES buffered solutions where HCs are mostly closed under resting conditions. The mechanism of HC opening with CO2 gassing is linked to carbamylation and authors pinpointed several Lys residues involved in this process. Overall, the work is interesting as it shows that Cx43 HCs have a significant open probability under resting conditions of physiological levels of CO2 gassing, probably applicable to/relevant for brain, heart and other Cx43 expressing organs. The paper gives a detailed account on various experiments performed (dye uptake, electrophysiology, ATP release to assess HC function) and results concluded from those. They further consider many candidate carbamylation sites by mutating them to negatively charged Glu residues. The paper finalizes with hippocampal slice work showing evidence for connexin-dependent increases of the EPSP amplitude that could be inhibited by HC inhibition with Gap26 (Fig. 10). Another line of evidence comes from the Cx43-linked ODDD genetic disease whereby L90V as well as the A44V mutations of Cx43 prevented the CO2 induced hemichannel opening response (Fig. 11). Although the paper is interesting, in its present state it suffers from (i) a problematic Fig. 3, precluding interpretation of the data shown, and (ii) the poor use of hemichannel inhibitors that are necessary to strengthen the evidence in the crucial experiment of Fig. 2 and others.</p>
<p>Comments on revisions:</p>
<p>The traces in Fig.2B show that the HC current is inward at 20 mmHg PCO2, while it switches to an outward current at 55mmHg PCO2. HCs are non-selective channels, so their current should switch direction around 0 mV but not around -50 mV. As such, the -50 mV switching point indicates involvement of another channel distinct from non-selective Cx43 hemichannels. In the revised version, this problem has not been solved nor addressed. Additionally, I identified another problem in that the experimental traces shown lack a trace at the baseline condition of PCO2 35mmHg, while the summary graph depicts a data point. Not showing a trace at baseline PCO2 35mmHg renders data interpretation in the summary graph questionable.</p>
</body>
</sub-article>
<sub-article id="sa4" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.105989.2.sa0</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dospinescu</surname>
<given-names>Valentin-Mihai</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mascarenhas</surname>
<given-names>Alexander</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Butler</surname>
<given-names>Jack</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nijjar</surname>
<given-names>Sarbjit</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Oliveira Taborda</surname>
<given-names>Kyara</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Connors</surname>
<given-names>Sean</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Lumei</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dale</surname>
<given-names>Nicholas</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2196-2949</contrib-id></contrib>
</contrib-group>
</front-stub>
<body>
<p>The following is the authors’ response to the original reviews.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #1 (Public review):</bold></p>
<p>Summary:</p>
<p>This study builds on previous work demonstrating that several beta connexins (Cx26, Cx30, and Cx32) have a carbamylation motif which renders them sensitive to CO<sub>2</sub>. In response to CO<sub>2</sub>, hemichannels composed of these connexins open, enabling diffusion of small molecules (such as ATP) between the cytosol and extracellular environment. Here, the authors have identified that an alpha connexin, Cx43, also contains a carbamylation motif, and they demonstrate that CO<sub>2</sub> opens Cx43 hemichannels. Most of the study involves using transfected cells expressing wildtype and mutant Cx43 to define amino acids required for CO<sub>2</sub> sensitivity. Hippocampal tissue slices in culture were used to show that CO<sub>2</sub>-induced synaptic transmission was affected by Cx43 hemichannels, providing a physiological context. The authors point out that the Cx43 gene significantly diverges from the beta connexins that are CO<sub>2</sub> sensitive, suggesting that the conserved carbamylation motif was present before the alpha and beta connexin genes diverged.</p>
<p>Strengths:</p>
<p>(1) The molecular analysis defining the amino acids that contribute to the CO<sub>2</sub> sensitivity of Cx43 is a major strength of the study. The rigor of analysis was strengthened by using three independent assays for hemichannel opening: dye uptake, patch clamp channel measurements, and ATP secretion. The resulting analysis identified key lysines in Cx43 that were required for CO<sub>2</sub>-mediated hemichannel opening. A double K to E Cx43 mutant produced a construct that produced hemichannels that were constitutively open, which further strengthened the analysis.</p>
<p>(2) Using hippocampal tissue sections to demonstrate that CO<sub>2</sub> can influence field excitatory postsynaptic potentials (fEPSPs) provides a native context for CO<sub>2</sub> regulation of Cx43 hemichannels. Cx43 mutations associated with Oculodentodigital Dysplasia (ODDD) inhibited CO<sub>2</sub>-induced hemichannel opening, although the mechanism by which this occurs was not elucidated.</p>
<p>Weaknesses:</p>
<p>(1) Cx43 channels are sensitive to cytosolic pH, which will be affected by CO<sub>2</sub>. Cytosolic pH was not measured, and how this affects CO<sub>2</sub>-induced Cx43 hemichannel activity was not addressed.</p>
</disp-quote>
<p>We have now addressed this with intracellular pH measurements and removal of the C-terminal pH sensor from Cx43 -the hemichannel remains CO<sub>2</sub> sensitive.</p>
<disp-quote content-type="editor-comment">
<p>(2) Cultured cells are typically grown in incubators containing 5% CO<sub>2</sub>, which is ~40 mmHg. It is unclear how cells would be viable if Cx43 hemichannels are open at this PCO2.</p>
</disp-quote>
<p>The cells look completely healthy with normal morphology and no sign of excessive cell death in the cultures. Presumably they have ways of compensating for the effects of partially open Cx43 hemichannels.</p>
<disp-quote content-type="editor-comment">
<p>(3) Experiments using Gap26 to inhibit Cx43 hemichannels in fEPSP measurements used a scrambled peptide as a control. Analysis should also include Gap peptides specifically targeting Cx26, Cx30, and Cx32 as additional controls.</p>
</disp-quote>
<p>We don’t feel this is necessary given the extensive prior literature in hippocampus showing the effect of ATP release via open Cx43 hemichannels on fEPSP amplitude that used astrocytic specific knockout of Cx43 and Gap26 (doi: 10.1523/jneurosci.0015-14.2014).</p>
<disp-quote content-type="editor-comment">
<p>(4) The mechanism by which ODDD mutations impair CO2-mediated hemichannel opening was not addressed. Also, the potential roles for inhibiting Cx43 hemichannels in the pathology of ODDD are unclear.</p>
</disp-quote>
<p>These pathological mutations that alter CO<sub>2</sub> sensitivity are similar to pathological mutation in Cx26 and Cx32, which also remove CO<sub>2</sub> sensitivity. Our cryo-EM studies on Cx26 give clues as to why these mutations have this effect -they alter conformational mobility of the channel (Brotherton et al 2022 doi: 10.1016/j.str.2022.02.010 and Brotherton et al 2024 doi: 10.7554/eLife.93686). We assume that similar considerations apply to Cx43, but this requires improved cryoEM structures of Cx43 hemichannels at differing levels of PCO<sub>2</sub>.</p>
<p>We agree that the link between loss of CO<sub>2</sub> sensitivity of Cx43 and ODDD is not established and have revised the text to make this clear.</p>
<disp-quote content-type="editor-comment">
<p>(5) CO2 has no effect on Cx43-mediated gap junctional communication as opposed to Cx26 gap junctions, which are inhibited by CO2. The molecular basis for this difference was not determined.</p>
</disp-quote>
<p>Cx26 gap junction channels are so far unique amongst CO<sub>2</sub> sensitive connexins in being closed by CO<sub>2</sub>. We have addressed the mechanism by which this occurs in Nijjar et al 2025 DOI: 10.1113/JP285885 -the requirement of carbamylation of K108 in Cx26 (in addition to K125) for GJC closure.</p>
<disp-quote content-type="editor-comment">
<p>(6) Whether there are other non-beta connexins that have a putative carbamylation motif was not addressed. Additional discussion/analysis of how the evolutionary trajectory for Cx43 maintaining a carbamylation motif is unique for non-beta connexins would strengthen the study.</p>
</disp-quote>
<p>We have performed a molecular phylogenetic survey to show that the carbamylation motif occurs across the alpha connexin clade and have shown that Cx50 is indeed CO<sub>2</sub> sensitive (doi: 10.1101/2025.01.23.634273). This is now in Fig 12.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Public review):</bold></p>
<p>Summary:</p>
<p>This paper examines the CO<sub>2</sub>  sensitivity of Cx43 hemichannels and gap junctional channels in transiently transfected Hela cells using several different assays, including ethidium dye uptake, ATP release, whole cell patch clamp recordings, and an imaging assay of gap junctional dye transfer. The results show that raising pCO<sub>2</sub> from 20 to 70 mmHg (at a constant pH of 7.3) causes an increase in opening of Cx43 hemichannels but does not block Cx43 gap junctions. This study also showed that raising pCO<sub>2</sub> from 20 to 35 mm Hg resulted in an increase in synaptic strength in hippocampal rat brain slices, presumably due to downstream ATP release, suggesting that the CO<sub>2</sub> sensitivity of Cx43 may be physiologically relevant. As a further test of the physiological relevance of the CO<sub>2</sub> sensitivity of Cx43, it was shown that two pathological mutations of Cx43 that are associated with ODDD caused loss of Cx43 CO<sub>2</sub>-sensitivity. Cx43 has a potential carbamylation motif that is homologous to the motif in Cx26. To understand the structural changes involved in CO<sub>2</sub> sensitivity, a number of mutations were made in Cx43 sites thought to be the equivalent of those known to be involved in the CO<sub>2</sub> sensitivity of Cx26, and the CO<sub>2</sub> sensitivity of these mutants was investigated.</p>
<p>Strengths:</p>
<p>This study shows that the apparent lack of functional Cx43 hemichannels observed in a number of previous in vitro function studies may be due to the use of HEPES to buffer the external pH. When Cx43 hemichannels were studied in external solutions in which CO<sub>2</sub>/bicarbonate was used to buffer pH instead of HEPES, Cx43 hemichannels showed significantly higher levels of dye uptake, ATP release, and ionic conductance. These findings may have major physiological implications since Cx43 hemichannels are found in many organs throughout the body, including the brain, heart, and immune system.</p>
<p>Weaknesses:</p>
<p>(1) Interpretation of the site-directed mutation studies is complicated. Although Cx43 has a potential carbamylation motif that is homologous to the motif in Cx26, the results of site-directed mutation studies were inconsistent with a simple model in which K144 and K105 interact following carbamylation to cause the opening of Cx43 hemichannels.</p>
</disp-quote>
<p>The mechanism of opening of Cx43 is more complex than that of Cx26, Cx32 and Cx50 and involves more Lys residues. The 4 Lys residues in Cx43 that are involved in opening the hemichannel have their equivalents in Cx26, but in Cx26 these additional residues seem to be involved in the closing of the GJC rather than opening of the hemichannel (see above). Cx50 is simpler and involves only two Lys residues (doi: 10.1101/2025.01.23.634273), which are equivalent to those in Cx26.</p>
<disp-quote content-type="editor-comment">
<p>(2) Secondly, although it is shown that two Cx43 ODDD-associated mutations show a loss of CO<sub>2</sub> sensitivity, there is no evidence that the absence of CO2 sensitivity is involved in the pathology of ODD</p>
</disp-quote>
<p>We agree, but this is probably because this has not been directly tested by experiment, as the CO<sub>2</sub> sensitivity of Cx43 was not previously known. As mentioned above we have revised the text to ensure that this is clear.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #3 (Public review):</bold></p>
<p>In this paper, the authors aimed to investigate carbamylation effects on the function of Cx43-based hemichannels. Such effects have previously been characterized for other connexins, e.g., for Cx26, which display increased hemichannel (HC) opening and closure of gap junction channels upon exposure to increased CO<sub>2</sub> partial pressure (accompanied by increased bicarbonate to keep pH constant).</p>
<p>The authors used HeLa cells transiently transfected with Cx43 to investigate CO<sub>2</sub> dependent carbamylation effects on Cx43 HC function. In contrast to Cx43-based gap junction channels that are reported here to be insensitive to PCO<sub>2</sub> alterations, they provide evidence that Cx43 HC opening is highly dependent on the PCO2 pressure in the bath solution, over a range of 20 up to 70 mmHg encompassing the physiologically normal resting level of around 40 mmHg. They furthermore identified several Cx43 residues involved in Cx43 HC sensitivity to PCO2: K105, K109, K144 &amp; K234; mutation of 2 or more of these AAs is necessary to abolish CO<sub>2</sub> sensitivity. The subject is interesting and the results indicate that a fraction of HCs is open at a physiological 40 mmHg PCO<sub>2</sub>, which differs from the situation under HEPES buffered solutions where HCs are mostly closed under resting conditions. The mechanism of HC opening with CO<sub>2</sub> gassing is linked to carbamylation, and the authors pinpointed several Lys residues involved in this process.</p>
<p>Overall, the work is interesting as it shows that Cx43 HCs have a significant open probability under resting conditions of physiological levels of CO<sub>2</sub> gassing, probably applicable to the brain, heart, and other Cx43 expressing organs. The paper gives a detailed account of various experiments performed (dye uptake, electrophysiology, ATP release to assess HC function) and results concluded from those. They further consider many candidate carbamylation sites by mutating them to negatively charged Glu residues. The paper ends with hippocampal slice work showing evidence for connexin-dependent increases of the EPSP amplitude that could be inhibited by HC inhibition with Gap26 (Figure 10). Another line of evidence comes from the Cx43-linked ODDD genetic disease, whereby L90V as well as the A44V mutations of Cx43 prevented the CO<sub>2</sub>-induced hemichannel opening response (Figure 11). Although the paper is interesting, in its present state, it suffers from (i) a problematic Figure 3, precluding interpretation of the data shown, and (ii) the poor use of hemichannel inhibitors that are necessary to strengthen the evidence in the crucial experiment of Figure 2 and others.</p>
</disp-quote>
<p>The panels in Figure 3 were mislabelled in the accompanying legend possibly leading to some confusion. This has now been corrected.</p>
<p>We disagree that hemichannel blockers are needed to strengthen the evidence in Figure 2 and other figures. Our controls show that the CO<sub>2</sub>-sensitive responses absolutely requires expression of Cx43 and was modified by mutations of Cx43. It is hard to see how this evidence would be strengthened by use of peptide inhibitors or other blockers of hemichannels that may not be completely selective.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewing Editor Comments:</bold></p>
<p>(1) Improve electrophysiological evidence, addressing concerns about the initial experiment and including peptide inhibitor data where applicable.</p>
</disp-quote>
<p>We think the concerns about the electrophysiological evidence arise from a misunderstanding because we gave insufficient information about how we conducted the experiments. We have now provided a much more complete legend, added explanations in the text and given more detail in the Methods. We further respond to the reviewer below.</p>
<p>We do not agree on the necessity of the peptide inhibitor to demonstrate dependence on Cx43.  We have shown that parental HeLa cells do not release ATP to changes in PCO<sub>2</sub> or voltage (Fig 2D; Butler &amp; Dale 2023, 10.3389/fncel.2023.1330983; Lovatt et al 2025, 10.1101/2025.03.12.642803, 10.1101/2025.01.23.634273). Our previous papers have shown many times that parental HeLa cells do not load with dye to CO<sub>2</sub> or zero Ca<sup>2+</sup> (e.g. Huckstepp et al 2010, 10.1113/jphysiol.2010.192096; Meigh et al 2013, 10.7554/eLife.01213; Meigh et al 2014, 10.7554/eLife.04249), and we have shown that parental HeLa cells do not exhibit the same CO<sub>2</sub> dependent change in whole cell conductance that the Cx43-expressing cells do (Fig 2B). In addition, we shown that mutating key residues in Cx43 alters both CO<sub>2</sub>-sensitive release of ATP and the CO<sub>2</sub>-dependent dye loading without affecting the respective positive control. To bolster this, we have included data for the K144R mutation as a supplement to Fig 3. Given the expense of Gap26 it is impractical to include this as a standard control and unnecessary given the comprehensive controls outlined.</p>
<p>Collectively, these data show that the responses to CO<sub>2</sub> require expression of Cx43 and can be modified by mutation of Cx43.</p>
<disp-quote content-type="editor-comment">
<p>(2) Strengthen the manuscript by measuring the effects of CO on cytosolic pH and Cx43 hemichannel opening. Consider using tail truncation mutants to assess the role of the C-terminal pH sensor in CO-mediated channel opening.</p>
</disp-quote>
<p>We agree and have performed the suggested experiments to address this issue.</p>
<disp-quote content-type="editor-comment">
<p>(3) Investigate the effect of expressing the K105E/K109E Cx43 double mutant on cell viability.</p>
</disp-quote>
<p>In our experiments the cells look completely healthy based on their morphology in brightfield microscopy and growth rates.</p>
<disp-quote content-type="editor-comment">
<p>(4) Discuss and analyze the uniqueness of Cx43 among alpha connexins in maintaining the carbamylation motif.</p>
</disp-quote>
<p>now discuss this -Cx43 is not unique. We have added a molecular phylogenetic survey of the alpha connexin clade in Fig 12. Apart from Cx37, the carbamylation motif appears in all the other members of the clade (but not necessarily in the human orthologue). In a different MS, currently posted on bioRxiv, we have documented the CO<sub>2</sub> sensitivity of Cx50 and its dependence on the motif.</p>
<disp-quote content-type="editor-comment">
<p>(5) Consider omitting data on ODDD-associated mutations unless there is evidence linking CO<sub>2</sub> sensitivity to disease pathology.</p>
</disp-quote>
<p>This experiment is observational, and we are not making claims that there is a direct causal link. Removing the ODDD mutant findings would lose potentially useful information for anyone studying how these mutations alter channel function. We have reworded the text to ensure that we say that the link between loss of CO<sub>2</sub> sensitivity and ODDD remains unproven.</p>
<disp-quote content-type="editor-comment">
<p>(6) Justify the choice of high K<sup>⁺</sup> and low external calcium as a positive control in ATP release experiments.</p>
</disp-quote>
<p>These two manipulations can open the hemichannel independently of the CO<sub>2</sub> stimulus. Extracellular Ca<sup>2+</sup> is well known to block all connexin hemichannels, and Cx43 is known to be voltage sensitive. The depolarisation from high K<sup>+</sup> is effective at opening the hemichannel and we preferred this as a more physiological way of opening the Cx43 hemichannel. We have added some explanatory text.</p>
<disp-quote content-type="editor-comment">
<p>(7) Clarify whether Cx43A44V or Cx43L90V mutations block gap junctional coupling.</p>
</disp-quote>
<p>This is an interesting point. Since Cx43 GJCs are not CO<sub>2</sub> sensitive we feel this is beyond the scope of our paper.</p>
<disp-quote content-type="editor-comment">
<p>(8) Discuss the potential implications of pCO₂ changes on myocardial function through alterations in intracellular pH.</p>
</disp-quote>
<p>We have modified the discussion to consider this point.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #1 (Recommendations for the authors):</bold></p>
<p>(1) Measurements of the effects of CO<sub>2</sub> on cytosolic pH/Cx43 hemichannel opening would strengthen the manuscript. Since the pH sensor of Cx43 is on the C terminus, the authors could consider making tail truncation mutants to see how this affects CO<sub>2</sub>-mediated Cx43 channel opening.</p>
</disp-quote>
<p>We have done this (truncating after residue 256) -the channel remains highly CO<sub>2</sub> and voltage sensitive. We have also documented the effect of the  hypercapnic solutions on intracellular pH measured with BCECF. These new data are now included as figure supplements to Figure 2.</p>
<disp-quote content-type="editor-comment">
<p>(2) What is the impact of expressing the K105E / K109E Cx43 double mutant on cell viability?</p>
</disp-quote>
<p>There was no obvious observed impact, cell density was as expected (no evidence of increased cell death), brightfield and fluorescence visualisation indicated normal healthy cells. We have added a movie (Fig 9, movie supplement 1) to show the effect of La<sup>3+</sup> on the GRAB<sub>ATP</sub> signal in cells expressing Cx43<sup>K105E, K109E</sup> so readers can appreciate the morphology and its stability during the recording.</p>
<disp-quote content-type="editor-comment">
<p>(3) A quick look at other alpha connexins suggested that Cx43 was unique among alpha connexins in maintaining the carbamylation motif. This merits additional discussion/ analysis.</p>
</disp-quote>
<p>This is an interesting point. Cx43 is not unique in the alpha clade in having the carbamylation motif as a number of other human alpha connexins also possess: Cx50, Cx59 and Cx62, and non-human alpha connexins (Cx40, Cx59, Cx46) also possess the motif. We have shown that Cx50 is CO<sub>2</sub> sensitive. We have performed a brief molecular phylogenetic analysis of the alpha connexon clade to highlight the occurrence of the carbamylation motif. This is now presented as Fig 12 to go with the accompanying discussion.</p>
<disp-quote content-type="editor-comment">
<p>(4) There were some minor writing issues that should be addressed. For instance, fEPSP is not defined. Also, insets showing positive controls in some experiments were not described in the figure legends.</p>
</disp-quote>
<p>We have corrected these issues.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Recommendations for the authors):</bold></p>
<p>(1) I would omit the data on the ODDD-associated mutations since there is no evidence that loss of CO<sub>2</sub> sensitivity plays an important role in the underlying disease pathology.</p>
</disp-quote>
<p>We are not making the claim CO<sub>2</sub> loss leads to the underlying pathology and have reviewed the text to ensure that we clearly express that this is a correlation not a cause. We think this is worth retaining as many pathological mutations in other CO<sub>2</sub> sensitive connexins (Cx26, Cx32 and Cx50) cause loss of CO<sub>2</sub> sensitivity, and this information may be helpful to other researchers.</p>
<disp-quote content-type="editor-comment">
<p>(2) Why is high K+ rather than low external calcium used as a positive control in ATP release experiments?</p>
</disp-quote>
<p>We used of high K<sup>+</sup> and depolarisation as a positive control as regard this as a more physiological stimulus than the low external Ca<sup>2+</sup>.</p>
<disp-quote content-type="editor-comment">
<p>(3) Does Cx43A44V or Cx43L90V block gap junctional coupling?</p>
</disp-quote>
<p>An interesting question but we have not examined this.</p>
<disp-quote content-type="editor-comment">
<p>(4) Provide references for biophysical recordings of Cx43 hemichannels performed in HEPES-buffered salines, which document Cx43 hemichannels as being shut.</p>
</disp-quote>
<p>have added the original and some later references which examine Cx43 hemichannel gating in HEPES buffer and shows the need for substantial depolarisation to induce channel opening.</p>
<disp-quote content-type="editor-comment">
<p>(5) In the heart muscle, changes in PCO<sub>2</sub> have long been hypothesized to cause changes in myocardial function by changing pHi.</p>
</disp-quote>
<p>This is true and we now add some discussion of this point. Now that we know that Cx43 is directly sensitive to CO<sub>2</sub> a direct action of CO<sub>2</sub> cannot be ruled out and careful experimentation is required to test this possibility.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #3 (Recommendations for the authors):</bold></p>
<p>(1) Page 3: &quot;... homologs of K125 and R104 ... &quot;: the context is linked to Cx26, so Cx26 needs to be added here.</p>
</disp-quote>
<p>Done</p>
<disp-quote content-type="editor-comment">
<p>(2) Page 4 text and related Figure 2:</p>
<p>(a) Figure 2A&amp;B: PCO2-dependent Cx43 HC opening is clearly present in the carboxy-fluorescein dye uptake experiments (Figure 2A) as well as in the electrophysiological experiments (Figure 2B). The curves look quite different between these two distinct readouts: dye uptake doubles from 20 to 70 mmHg in Figure 2A while the electrophysiological data double from 45 to 70 mmHg in Figure 2B. These responses look quite distinct and may be linked to a non-linearity of the dye uptake assay or a problem in the electrophysiological measurements of Figure 2B discussed in the next point.</p>
</disp-quote>
<p>Different molecules/ions may have different permeabilities through the channel, which could explain the observed difference. Also, there is some contamination of the whole cell conductance change with another conductance (evident in recordings from parental HeLa cells). This is evident particularly at 70 mmHg. If this contaminating conductance were subtracted from the total conductance in the Cx43 expressing cells, then the dose response relations would be more similar. However, we are reluctant to add this additional data processing step to the paper.</p>
<disp-quote content-type="editor-comment">
<p>(b) The traces in Figure 2B show that the HC current is inward at 20 mmHg PCO2, while it switches to an outward current at 55mmHg PCO2. HCs are non-selective channels, so their current should switch direction around 0 mV but not at -50 mV. As such, the -50 mV switching point indicates involvement of another channel distinct from non-selective Cx43 hemichannels.</p>
</disp-quote>
<p>We think that our incomplete description in the legend led to this misunderstanding. We used a baseline of 35 mmHg (where the channels will be slightly open) and changed to 20 mmHg to close them (or to higher PCO<sub>2</sub> to open them from this baseline), hence a decrease in conductance and loss of outward current for 20 mmHg. The holding potential for the recordings and voltage steps were the same in all recordings. We have now edited the legend and added more information into the methods to clarify this and how we constructed the dose response curve.</p>
<p>We agree that Cx43 hemichannels are relatively nonselective and would normally be expected to have a reversal potential around 0 mV, but we are using K-Gluconate and the lowered reversal potential (~-65 mV) is likely due to poor permeation of this anion via Cx43.</p>
<disp-quote content-type="editor-comment">
<p>(c) A Hill slope of 6 is reported for this curve, which is extremely steep. The paper does not provide any further consideration, making this an isolated statement without any theoretical framework to understand the present finding in such context (i.e., in relation to the PCO2 dependency of Cx channels).</p>
</disp-quote>
<p>Yes, we agree -it seems to be the case with all CO<sub>2</sub> sensitive connexins that we have looked at that the Hill coefficient versus CO<sub>2</sub> is &gt;4. Hemichannels are of course hexameric so there is potential for 6 CO<sub>2</sub> molecules to be bound and extensive cooperativity. We have modified the text to give greater context.</p>
<disp-quote content-type="editor-comment">
<p>(d) A further remark to Figure 2 is that it does not contain any experiment showing the effect of Cx43 hemichannel inhibition with a reliable HC inhibitor such as Gap26, which is only used in the penultimate illustration of Figure 10. Gap26 should be used in Figure 2 and most of the other figures to show evidence of HC contribution. The lanthanum ions used in Figure 9 are a very non-specific hemichannel blocker and should be replaced by experiments with Gap26.</p>
</disp-quote>
<p>We have addressed the first part of this comment above.</p>
<p>We agree that La<sup>3+</sup> blocks all hemichannels, but in the context of our experiments and the controls we have performed it is entirely adequate and supports our conclusions. Our controls show (mentioned above and below) show that the expression of Cx43 is absolutely required for CO<sub>2</sub>-dependent ATP release (and dye loading). In Figure 9 our use of La<sup>3+</sup> was to show the presence of a constitutively open Cx43 mutant hemichannel. Gap26 would add little to this. Our further controls show that with expression of Cx43<sup>WT</sup> La<sup>3+</sup> did nothing to the ATP signal under baseline conditions (20 mmHg) supporting our conclusion that the mutant channels are constitutively open.</p>
<disp-quote content-type="editor-comment">
<p>(e) As the experiments of Figure 2 form the basis of what is to follow, the above remarks cast doubt on the robustness of the experiments and the data produced.</p>
</disp-quote>
<p>We disagree, our results are extremely robust: 1) we have used three independent assays confirm the presence of the response; 2) parental HeLa cells do not release ATP, dye load or show large conductance changes to CO<sub>2</sub> showing the absolute requirement for expression of Cx43; 3) mutations of Cx43 (in the carbamylation motif) alter the CO<sub>2</sub> evoked ATP release and dye loading giving further confirmation of Cx43 as the conduit for ATP release and dye loading; and 4) we use standard positive controls (0 Ca<sup>²</sup>, high K<sup/>) to confirm cells still have functional channels for those mutations that modified CO<sub>2</sub> sensitivity.</p>
<disp-quote content-type="editor-comment">
<p>(f) The sentence &quot;Cells transfected with GRAB-ATP only, showed ... &quot; should be</p>
</disp-quote>
<p>modified to &quot;In contrast, cells not expressing Cx43 showed no responses to any applied CO2 concentration as concluded from GRAB-ATP experiments&quot;</p>
<p>We have modified the text.</p>
<disp-quote content-type="editor-comment">
<p>(3) Page 5 and Figures 3 &amp; 4:</p>
<p>(a) Figure 3 illustrates results obtained with mutations of 4 distinct Lys residues. However, the corresponding legend indicates mutations that are different from the ones shown in the corresponding illustrations, making it impossible to reliably understand and interpret the results shown in panels A-E.</p>
</disp-quote>
<p>Thanks for pointing this out. Our apologies, we modified the figure so that the order of the images matched the order of the graph (and the legend) but then forgot to put the new version of the figure in the text. We have now corrected this so that Figure and legend match.</p>
<disp-quote content-type="editor-comment">
<p>(b) Figure 4 lacks control WT traces!</p>
</disp-quote>
<p>The controls for this (showing that parental HeLa cells do not release ATP in response to CO<sub>2</sub> or depolarisation) are shown in Figure 2.</p>
<disp-quote content-type="editor-comment">
<p>(c) Figure 4, Supplement 1: High Hill coefficients of 10 are shown here, but they are not discussed anywhere, as is also the case for the remark on p.4. A Hill steepness of 10 is huge and points to many processes potentially involved. As reported above, these data are floating around in the manuscript without any connection.</p>
</disp-quote>
<p>Yes, we agree this is very high and surprising. It may reflect as mentioned above the hexameric nature of the channel and that 4 Lys residues seem to be involved. We have used this equation to give some quantitative understanding of the effect of the mutations on CO<sub>2</sub> sensitivity and still think this is useful. We have no further evidence to interpret these values one way or the other.</p>
<disp-quote content-type="editor-comment">
<p>(4) Page 6: Carbamate bridges are proposed to be formed between K105 and K144, and between K109 and K234. The first three of these Lysine residues are located in the 55aa long cytoplasmic loop of Cx43, while K234 is in the juxta membrane region involved in tubulin interactions. Both K144 and and K234 are involved in Cx43 HC inhibition: K144 is the last aa of the L2 peptide (D119-K144 sequence) that inhibits Cx43 hemichannels while K234 is the first aa of the TM2 peptide that reduces hemichannel presence in the membrane (sequence just after TM4, at the start of the C-tail). This context should be added to increase insight and understanding of the CO2 carbamylation effects on Cx43 hemichannel opening.</p>
</disp-quote>
<p>Thanks for suggesting this. We have added some discussion of CT to CL interactions in the context of regulation by pH and [Ca<sup>2+</sup>].</p>
<disp-quote content-type="editor-comment">
<p>(5) Page 7: The Cx43 ODDD A44V and L90V mutations lead to loss of pCO2 sensitivity in dye loading and ATP assays. However, A44V located in EL1 is reportedly associated with Cx43 HC activation, while L90V in TM2 is associated with HC inhibition. Remarkably, these mutations are focused on non-Lys residues, which brings up the question of how to link this to the paper's main thread.</p>
</disp-quote>
<p>This follows the pattern that we have seen for other mutations such as A40V, A88V in Cx26 and several CMTX mutations of Cx32. Our cryoEM structures of Cx26 suggest that these mutations alter the flexibility of the molecule and hence abolish CO<sub>2</sub> sensitivity. We have reworded the text to avoid giving the impression that there is a demonstrated link between loss of CO<sub>2</sub> sensitivity of Cx43 and pathology.</p>
<disp-quote content-type="editor-comment">
<p>(6) Page 8: HCs constitutively open - 'constutively' perhaps does not have the best connotation as it is not related to HC constitution but CO2 partial pressure.</p>
</disp-quote>
<p>Yes, we agree and have reworded this.</p>
<disp-quote content-type="editor-comment">
<p>(7) Page 9: &quot;in all subtypes&quot; -&gt; not clear what is meant - do you mean &quot;in all cell types&quot;?</p>
</disp-quote>
<p>We agree this is unclear -it refers to all astrocytic subtypes. We have amended the text.</p>
<disp-quote content-type="editor-comment">
<p>(8) Page 10: Composition of hypocapnic recording solution: bubbling description is incomplete &quot;95%O2/5%&quot; and should be &quot;95%O2/5%CO2&quot;.</p>
</disp-quote>
<p>Changed.</p>
<disp-quote content-type="editor-comment">
<p>(9) Page 11: Composition of zero Ca<sup>²⁺</sup> hypocapnic recording solution: perhaps better to call this &quot;nominally Ca<sup>²⁺</sup>-free hypocapnic recording solution&quot; as no Ca<sup>²⁺</sup> buffer is included in this solution</p>
</disp-quote>
<p>Thanks for pointing this out. We did in fact add 1 mM EGTA to the solutions but omitted this from the recipe, this has now been corrected.</p>
<disp-quote content-type="editor-comment">
<p>(10) Page 11: in M&amp;M I found that the NaHCO3- is lowered to 10 mM in the zero Ca<sup>²⁺</sup>condition, while the control experimental condition has 26 mM NaHCO3-. The zero Ca condition should be kept at a physiologically normal 26 mM NaHCO3- concentration, so why was this done? Lowering NaHCO3- during hemichannel stimulation may result in smaller responses and introduce non-linearities.</p>
</disp-quote>
<p>For the dye loading we used 20 mmHg as the baseline condition and increased PCO<sub>2</sub> from this. Hence for the zero Ca<sup>2+</sup> positive control we modified the 20 mmHg hypocapnic solution by substituting Mg<sup>2+</sup> for Ca<sup>2+</sup> and adding EGTA. We have modified the text in the Methods to clarify this.</p>
<disp-quote content-type="editor-comment">
<p>Further remarks on the figures:</p>
<p>(1) Figure 2A: Add 20 &amp; 70 mmHg to the images, to improve the readability of this illustration.</p>
</disp-quote>
<p>Done</p>
<disp-quote content-type="editor-comment">
<p>(2) Figure 3: WT responses are shown in panel F, but experimental data (images and curves) are lacking and should be included in a revised version.</p>
</disp-quote>
<p>The wild type data is shown in Fig 2A. We have some sympathy for the comment, but we felt that Fig 2 should document CO<sub>2</sub> sensitivity, and then the subsequent Figs should analyse its basis. Hence the separation of Cx43<sup>WT</sup> data from the mutant data. In panel F, we state that we have recalculated the WT data from Fig 2A to allow the comparison.</p>
<disp-quote content-type="editor-comment">
<p>(3) Figures 4, 6, 8: Color codes for mmHg CO<sub>2</sub> pressure make reading these figures difficult; perhaps better to add mmHg values directly in relation to the traces.</p>
</disp-quote>
<p>We have considered this suggestion but feel that the figures would become very cluttered with the additional labelling.</p>
<disp-quote content-type="editor-comment">
<p>(4) I wouldn't use colored lines when not necessary, e.g., Figure 9 100 µM La3+; Figure 10 (add 20-&gt;35 mmHg PCO2 switch; add scrGap26 above blue bars); Figure 11C &amp; D.</p>
</disp-quote>
<p>We agree and can see that in Figs 9 and 10 this muddles our colour scheme in other figures so have modified these figures. There was not space to put the suggested labels.</p>
<disp-quote content-type="editor-comment">
<p>(5) The mechanism of increased HC opening is not clear.</p>
</disp-quote>
<p>We agree and have discussed various options and the analogy with what we know about Cx26. Ultimately new cryo-EM data is required.</p>
<disp-quote content-type="editor-comment">
<p>(6) Figure 10: 35G/35S are weird abbreviations for 35 mmHg Gap26 and scrambled Gap26.</p>
</disp-quote>
<p>Yes, but we used these to fit into the available space.</p>
<disp-quote content-type="editor-comment">
<p>(7) Figure 11, legend: '20 mmHg PCO2 for each transfection for 70 mmHg PCO2'. It is not clear what is meant here.</p>
</disp-quote>
<p>Thanks for pointing this out, we have reworded this to ensure clarity.</p>
</body>
</sub-article>
</article>